PMID
Article Title
Citation
Organization
Download
View Data
Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy.
J Med Chem 60: 8847-8857 (2017)
Crystal Pharmatech
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors.
Bioorg Med Chem Lett 27: 4812-4816 (2017)
Universit£
Phenotypic Optimization of Urea-Thiophene Carboxamides To Yield Potent, Well Tolerated, and Orally Active Protective Agents against Aminoglycoside-Induced Hearing Loss.
J Med Chem 61: 84-97 (2018)
University Of Washington
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.
J Med Chem 60: 8989-9002 (2017)
Celgene
Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KIT.
J Med Chem 60: 8801-8815 (2017)
Tu Dortmund University
Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/?-Aminobutyric Acid Transporter 1 (BGT1).
J Med Chem 60: 8834-8846 (2017)
University Of Copenhagen
Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism.
J Med Chem 60: 8631-8646 (2017)
Dongguk University
Peptide therapeutics from venom: Current status and potential.
Bioorg Med Chem 26: 2738-2758 (2018)
Peptides International
Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes.
Bioorg Med Chem 25: 5995-6006 (2017)
Takeda Pharmaceutical
Challenges in the design of insulin and relaxin/insulin-like peptide mimetics.
Bioorg Med Chem 26: 2827-2841 (2018)
University Of Melbourne
Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
Bioorg Med Chem 25: 5917-5928 (2017)
Shenyang Pharmaceutical University
Synthesis and structure activity relationships of carbamimidoylcarbamate derivatives as novel vascular adhesion protein-1 inhibitors.
Bioorg Med Chem 25: 6024-6038 (2017)
Astellas Pharma
Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes.
Eur J Med Chem 140: 448-464 (2017)
Shanghai Institute Of Materia Medica
Synthesis of naphthazarin derivatives and identification of novel thioredoxin reductase inhibitor as potential anticancer agent.
Eur J Med Chem 140: 435-447 (2017)
Lanzhou University
Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro.
Eur J Med Chem 140: 421-434 (2017)
China Pharmaceutical University
Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
Eur J Med Chem 140: 392-402 (2017)
Xinxiang Medical University
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.
Eur J Med Chem 140: 383-391 (2017)
Shandong University
Covalent binding design strategy: A prospective method for discovery of potent targeted anticancer agents.
Eur J Med Chem 142: 493-505 (2017)
Dalian Medical University
9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Bioorg Med Chem 25: 5981-5994 (2017)
Institute Of Physiologically Active Compounds Russian Academy Of Sciences
Synthesis of photocaged 6-O-(2-nitrobenzyl)guanosine and 4-O-(2-nitrobenzyl) uridine triphosphates for photocontrol of the RNA transcription reaction.
Bioorg Med Chem 25: 6007-6015 (2017)
Tokyo Institute Of Technology
Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition.
Bioorg Med Chem Lett 27: 4838-4843 (2017)
Glaxosmithkline
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease.
J Med Chem 60: 8858-8875 (2017)
Columbia University
C-Methylated Flavonoid Glycosides from Pentarhizidium orientale Rhizomes and Their Inhibitory Effects on the H1N1 Influenza Virus.
J Nat Prod 80: 2818-2824 (2017)
Seoul National University
Chemical Approaches to Modulating Complement-Mediated Diseases.
J Med Chem 61: 3253-3276 (2018)
The University Of Queensland
Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.
J Med Chem 60: 8441-8455 (2017)
Gifu Pharmaceutical University
Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors.
Bioorg Med Chem Lett 27: 4832-4837 (2017)
St. John'S University
Berchemiosides A-C, 2-Acetoxy-?-phenylpentaene Fatty Acid Triglycosides from the Unripe Fruits of Berchemia berchemiifolia.
J Nat Prod 80: 2778-2786 (2017)
Seoul National University
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists.
J Med Chem 60: 8716-8730 (2017)
University Of Copenhagen
Modulators of 14-3-3 Protein-Protein Interactions.
J Med Chem 61: 3755-3778 (2018)
Eindhoven University Of Technology
Potential Anti-inflammatory Effects of the Fruits of Paulownia tomentosa.
J Nat Prod 80: 2659-2665 (2017)
Korea Research Institute Of Bioscience And Biotechnology
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.
J Med Chem 60: 8647-8660 (2017)
S£O Paulo State University (Unesp)
New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
Eur J Med Chem 140: 305-320 (2017)
Ludwig-Maximilians-University Munich
Pentacyclic triterpenes as?-glucosidase and?-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
Bioorg Med Chem Lett 27: 5065-5070 (2017)
Dalian University Of Technology
Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors: Design, synthesis, biological evaluation and computational studies.
Eur J Med Chem 140: 293-304 (2017)
China Pharmaceutical University
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.
Bioorg Med Chem 25: 5849-5858 (2017)
University Of Genoa
Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
Bioorg Med Chem 25: 5185-5193 (2017)
Konkuk University
Synthesis and biological evaluation of sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474.
Bioorg Med Chem 25: 5859-5874 (2017)
University Of Auckland
Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
Bioorg Med Chem Lett 27: 4858-4866 (2017)
Vanderbilt University
Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H
Bioorg Med Chem Lett 27: 4914-4919 (2017)
Glaxosmithkline
Plasma-induced dimerization of phloridzin as a new class of anti-adipogenic agents.
Bioorg Med Chem Lett 27: 4889-4892 (2017)
Daegu University
Discovery and SAR of a novel series of Natriuretic Peptide Receptor-A (NPR-A) agonists.
Bioorg Med Chem Lett 27: 4904-4907 (2017)
Asubio Pharma
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML.
J Med Chem 60: 8407-8424 (2017)
Chinese Academy Of Sciences
Vitamin D Analogues with a p-Hydroxyphenyl Group at the C25 Position: Crystal Structure of Vitamin D Receptor Ligand-Binding Domain Complexed with the Ligand Explains the Mechanism Underlying Full Antagonistic Action.
J Med Chem 60: 8394-8406 (2017)
Showa Pharmaceutical University
Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor.
J Med Chem 60: 9585-9598 (2017)
Zhaw Zurich University Of Applied Sciences
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.
J Med Chem 60: 8336-8357 (2017)
National University Of Singapore
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
J Med Chem 60: 8011-8026 (2017)
Anacor Pharmaceuticals
Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.
Bioorg Med Chem 25: 5799-5819 (2017)
Advinus Therapeutics
Thioether-stapled macrocyclic inhibitors of the EH domain of EHD1.
Bioorg Med Chem 26: 1206-1211 (2018)
Tufts University
The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrP
Bioorg Med Chem 25: 5875-5888 (2017)
University Of Alberta
PTP1B inhibitors from the seeds of Iris sanguinea and their insulin mimetic activities via AMPK and ACC phosphorylation.
Bioorg Med Chem Lett 27: 5076-5081 (2017)
Seoul National University
Exploring Heme and Hemoglobin Binding Regions of Plasmodium Heme Detoxification Protein for New Antimalarial Discovery.
J Med Chem 60: 8298-8308 (2017)
International Centre For Genetic Engineering And Biotechnology
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor.
J Med Chem 60: 8369-8384 (2017)
Abbvie
Molecular Basis for Allosteric Inhibition of Acid-Sensing Ion Channel 1a by Ibuprofen.
J Med Chem 60: 8192-8200 (2017)
University Of Copenhagen
Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists.
ACS Med Chem Lett 8: 981-986 (2017)
Astrazeneca
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.
ACS Med Chem Lett 8: 975-980 (2017)
Novartis Institutes For Biomedical Research
Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-
ACS Med Chem Lett 8: 969-974 (2017)
Wuxi Apptec (Shanghai)
Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors.
ACS Med Chem Lett 8: 963-968 (2017)
University Of Florence
Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 Diabetes.
ACS Med Chem Lett 8: 947-952 (2017)
Janssen Research And Development
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors.
ACS Med Chem Lett 8: 941-946 (2017)
University Of Sassari
Design of Selective Benzoxazepin PI3K? Inhibitors Through Control of Dihedral Angles.
ACS Med Chem Lett 8: 936-940 (2017)
Genentech
Design and Synthesis of
ACS Med Chem Lett 8: 925-930 (2017)
Vanderbilt University School Of Medicine
Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand.
ACS Med Chem Lett 8: 914-918 (2017)
University Of Iowa
Bruton's Tyrosine Kinase Inhibitors for the Treatment of Autoimmune Diseases and Cancers.
ACS Med Chem Lett 8: 911-913 (2017)
Amri
New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders.
ACS Med Chem Lett 8: 908-910 (2017)
Amri
Modulating GluN2B for the Treatment of Neurological and Psychiatric Disorders.
ACS Med Chem Lett 8: 905-907 (2017)
Amri
Discovery of N-substituted 7-azaindoles as PIM1 kinase inhibitors - Part I.
Bioorg Med Chem Lett 27: 4730-4734 (2017)
Sanofi Genzyme
Design, synthesis and biological evaluation of novel histone deacetylase inhibitors incorporating 4-aminoquinazolinyl systems as capping groups.
Bioorg Med Chem Lett 27: 4885-4888 (2017)
Shanghai Institute Of Pharmaceutical Industry
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors.
Bioorg Med Chem Lett 27: 4908-4913 (2017)
Bristol-Myers Squibb
In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery.
J Med Chem 60: 8552-8564 (2017)
National Institute Of Biological Sciences, Beijing
New 5-HT
Bioorg Med Chem 25: 5820-5837 (2017)
Dipartimento Di Farmacia Universit£
Structure-activity relationship study of?-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists.
Bioorg Med Chem Lett 27: 4770-4776 (2017)
Florida Institute Of Technology
Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ER?/VEGFR-2 ligands for treatment of breast cancer.
Eur J Med Chem 140: 252-273 (2017)
China Pharmaceutical University
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.
Bioorg Med Chem Lett 27: 4606-4613 (2017)
Korea Research Institute Of Chemical Technology
Continued SAR exploration of 1,2,4-thiadiazole-containing scaffolds in the design of free fatty acid receptor 1 (GPR40) agonists.
Eur J Med Chem 140: 229-238 (2017)
Saint Petersburg State University
Synthesis and biological evaluation of novel 6,11-dihydro-5H-benzo[e]pyrimido- [5,4-b][1,4]diazepine derivatives as potential c-Met inhibitors.
Eur J Med Chem 140: 212-228 (2017)
Shanghai Institute Of Pharmaceutical Industry
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
J Med Chem 60: 8425-8440 (2017)
University Of Bonn
Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.
J Med Chem 60: 8591-8605 (2017)
Astrazeneca
A potent neuromedin U receptor 2-selective alkylated peptide.
Bioorg Med Chem Lett 27: 4626-4629 (2017)
Takeda Pharmaceutical
Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay.
PLoS ONE 12: 1-16 (2017)
Pfizer
Design and Structure-Guided Development of Novel Inhibitors of the Xeroderma Pigmentosum Group A (XPA) Protein-DNA Interaction.
J Med Chem 60: 8055-8070 (2017)
Indiana University School Of Medicine
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
J Med Chem 60: 9976-9989 (2017)
University Of California
Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.
J Med Chem 60: 8170-8182 (2017)
University Of Minnesota
Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer's Disease.
J Med Chem 60: 8083-8102 (2017)
Wuxi Apptec
Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
J Med Chem 60: 8160-8169 (2017)
Stockholm University
Structural Biology-Inspired Discovery of Novel KRAS-PDE? Inhibitors.
J Med Chem 60: 9400-9406 (2017)
Second Military Medical University
In-cell production of a genetically-encoded library based on the ?-defensin RTD-1 using a bacterial expression system.
Bioorg Med Chem 26: 1212-1219 (2018)
University Of Southern California
Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
Bioorg Med Chem 25: 5754-5763 (2017)
Jiangxi Science & Technology Normal University
Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1.
Bioorg Med Chem Lett 27: 4755-4759 (2017)
University Of Manchester
Synthesis and evaluation of the NSCLC anti-cancer activity and physical properties of 4-aryl-N-phenylpyrimidin-2-amines.
Bioorg Med Chem Lett 27: 4749-4754 (2017)
Kasetsart University
Discovery and optimization of oxadiazole-based FLAP inhibitors.
Bioorg Med Chem Lett 27: 4652-4659 (2017)
Boehringer Ingelheim Pharmaceuticals
Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II.
Bioorg Med Chem Lett 27: 4735-4740 (2017)
Sanofi Genzyme
Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
Bioorg Med Chem Lett 27: 4635-4642 (2017)
Ningxia Medical University
Discovery of highly potent, selective, covalent inhibitors of JAK3.
Bioorg Med Chem Lett 27: 4622-4625 (2017)
Bristol-Myers Squibb Research And Development
Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
Eur J Med Chem 140: 187-199 (2017)
University Of S£O Paulo
Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.
J Med Chem 61: 2636-2651 (2018)
Abbvie
Are We There Yet? Applying Thermodynamic and Kinetic Profiling on Embryonic Ectoderm Development (EED) Hit-to-Lead Program.
J Med Chem 60: 8321-8335 (2017)
Abbvie
Nanomolar Inhibitors of Glycogen Phosphorylase Based on?-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.
J Med Chem 60: 9251-9262 (2017)
University Of Debrecen
Targeting breast cancer stem cells by novel HDAC3-selective inhibitors.
Eur J Med Chem 140: 42-51 (2017)
National Taiwan University
Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
Eur J Med Chem 140: 155-171 (2017)
Shenyang Pharmaceutical University
Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Eur J Med Chem 140: 118-127 (2017)
Xinyang Normal University
Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological Activity.
J Med Chem 60: 8115-8130 (2017)
Universit£
Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation.
J Med Chem 60: 7820-7834 (2017)
University Of Wisconsin-Madison
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase II?.
Bioorg Med Chem Lett 27: 4687-4693 (2017)
Alma Mater Studiorum-University Of Bologna
Identifying novel factor XIIa inhibitors with PCA-GA-SVM developed vHTS models.
Eur J Med Chem 140: 31-41 (2017)
The University Of Akron
Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors.
Eur J Med Chem 140: 20-30 (2017)
South China University Of Technology
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
Eur J Med Chem 140: 1-19 (2017)
Nirma University
Highly potent antiobesity effect of a short-length peptide YY analog in mice.
Bioorg Med Chem 25: 5718-5725 (2017)
Takeda Pharmaceutical
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.
Bioorg Med Chem Lett 27: 4698-4704 (2017)
St. John'S University
Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration.
Bioorg Med Chem Lett 27: 4673-4677 (2017)
Glaxosmithkline
d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions.
Bioorg Med Chem Lett 27: 4678-4681 (2017)
University Of Maryland
Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action.
Bioorg Med Chem 25: 5637-5651 (2017)
Umm Al-Qura University
Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.
Eur J Med Chem 142: 424-458 (2017)
Central University Of Punjab
Direct NMR Probing of Hydration Shells of Protein Ligand Interfaces and Its Application to Drug Design.
J Med Chem 60: 8708-8715 (2017)
University Of Vienna
Discovery, Structure-Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4.
J Med Chem 60: 8515-8537 (2017)
Prexton Therapeutics
Acetylcholinesterase Inhibitory Alkaloids from the Whole Plants of Zephyranthes carinata.
J Nat Prod 80: 2462-2471 (2017)
Huazhong University Of Science And Technology
Microcystins: Synthesis and structure-activity relationship studies toward PP1 and PP2A.
Bioorg Med Chem 26: 1118-1126 (2018)
European Molecular Biology Laboratory (EMBL)
Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1.
J Med Chem 60: 7984-7999 (2017)
University Of Manchester
Inhibitors of the Diadenosine Tetraphosphate Phosphorylase Rv2613c of Mycobacterium tuberculosis.
ACS Chem Biol 12: 2682-2689 (2017)
University Of Konstanz
Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1).
J Med Chem 60: 8246-8252 (2017)
National Cancer Institute-Bethesda
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP).
J Med Chem 60: 9162-9183 (2017)
Genentech
Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Bioorg Med Chem 25: 5709-5717 (2017)
South China Agricultural University
Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
Bioorg Med Chem 25: 5726-5732 (2017)
National Institute Of Pharmaceutical Education And Research (Niper)
Analysis of the binding sites of vitamin D 1?-hydroxylase (CYP27B1) and vitamin D 24-hydroxylase (CYP24A1) for the design of selective CYP24A1 inhibitors: Homology modelling, molecular dynamics simulations and identification of key binding requirements.
Bioorg Med Chem 25: 5629-5636 (2017)
Cardiff University
A prodrug design for improved oral absorption and reduced hepatic interaction.
Bioorg Med Chem 25: 5569-5575 (2017)
Evestra
Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
Eur J Med Chem 139: 961-981 (2017)
Svkm'S Dr. Bhanuben Nanavati College Of Pharmacy
Lipid Peroxidation and Cyclooxygenase Enzyme Inhibitory Compounds from Prangos haussknechtii.
J Nat Prod 80: 2472-2477 (2017)
Michigan State University
Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors.
J Med Chem 60: 7965-7983 (2017)
Second Military Medical University
Sulfonium as a Surrogate for Ammonium: A New?7 Nicotinic Acetylcholine Receptor Partial Agonist with Desensitizing Activity.
J Med Chem 60: 7928-7934 (2017)
University Of Florida
Design and synthesis of benzoacridines as estrogenic and anti-estrogenic agents.
Bioorg Med Chem 25: 5216-5237 (2017)
Kyushu University
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.
Eur J Med Chem 139: 936-946 (2017)
University Of Torino
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
J Med Chem 60: 8145-8159 (2017)
East China University Of Science And Technology
Namalides B and C and Spumigins K-N from the Cultured Freshwater Cyanobacterium Sphaerospermopsis torques-reginae.
J Nat Prod 80: 2492-2501 (2017)
University Of S£O Paulo
Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain.
J Med Chem 61: 2652-2679 (2018)
Albany College Of Pharmacy And Health Sciences
Discovery of Novel Macrocyclic Hedgehog Pathway Inhibitors Acting by Suppressing the Gli-Mediated Transcription.
J Med Chem 60: 8218-8245 (2017)
Shanghai Institute Of Materia Medica (Simm)
?-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.
Bioorg Med Chem 25: 5613-5628 (2017)
Friedrich-Alexander University Erlangen-N£Rnberg
1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
Bioorg Med Chem 25: 5548-5556 (2017)
Shandong University
Discovery of a novel, CNS penetrant M
Bioorg Med Chem Lett 27: 4274-4279 (2017)
Vanderbilt University
Synthesis, in vitro ?-glucuronidase inhibitory potential and molecular docking studies of quinolines.
Eur J Med Chem 139: 849-864 (2017)
University Of Karachi
Study on the design, synthesis and structure-activity relationships of new thiosemicarbazone compounds as tyrosinase inhibitors.
Eur J Med Chem 139: 815-825 (2017)
Sun Yat-Sen University
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.
Eur J Med Chem 139: 773-791 (2017)
University Of S£O Paulo
Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia.
Eur J Med Chem 139: 762-772 (2017)
University Of South Australia
Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.
Eur J Med Chem 139: 726-740 (2017)
Wenzhou Medical University
1-Aryl-1H- and 2-aryl-2H-1,2,3-triazole derivatives blockade P2X7 receptor in vitro and inflammatory response in vivo.
Eur J Med Chem 139: 698-717 (2017)
Instituto De Tecnologia Em F£Rmacos
Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma.
J Med Chem 60: 8131-8144 (2017)
Mayo Clinic
Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.
J Med Chem 60: 7910-7927 (2017)
University Of Ottawa
Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5.
J Med Chem 60: 7781-7798 (2017)
University Of Helsinki
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK).
J Med Chem 60: 7835-7849 (2017)
Pfizer
Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrroli
J Med Chem 61: 599-618 (2018)
University Of Dundee
Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor.
J Med Chem 60: 7725-7744 (2017)
Tu Dortmund University
Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC.
Eur J Med Chem 139: 674-697 (2017)
Chinese Academy Of Sciences
Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry.
J Med Chem 61: 2166-2210 (2018)
St. John'S University
Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation.
ACS Chem Biol 12: 2619-2630 (2017)
Oxford University
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.
J Med Chem 60: 7703-7724 (2017)
Goethe-University Frankfurt
Picomolar inhibition of?-galactosidase (bovine liver) attributed to loop closure.
Bioorg Med Chem 25: 5194-5202 (2017)
University Of Arkansas
Recent developments in small molecule therapies for renal cell carcinoma.
Eur J Med Chem 142: 383-392 (2017)
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting.
Bioorg Med Chem Lett 27: 4229-4237 (2017)
Eberhard-Karls-University Tuebingen
Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids.
Bioorg Med Chem Lett 27: 4358-4369 (2017)
Beni-Suef University
Synthesis, pH dependent, plasma and enzymatic stability of bergenin prodrugs for potential use against rheumatoid arthritis.
Bioorg Med Chem 25: 5513-5521 (2017)
Csir-Indian Institute Of Integrative Medicine
Photoactivation provides a mechanistic explanation for pan-assay interference behaviour of 2-aminopyrroles in lipoxygenase inhibition.
Eur J Med Chem 139: 633-643 (2017)
University Of Groningen
A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease.
Eur J Med Chem 139: 612-632 (2017)
The University Of Sydney
Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2).
Eur J Med Chem 139: 587-611 (2017)
University Of Bonn
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors.
ACS Chem Biol 12: 2491-2497 (2017)
Istituto Italiano Di Tecnologia
Conjugates of 18?-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Bioorg Med Chem 25: 5441-5451 (2017)
Shenyang Pharmaceutical University
Synthesis and biological evaluation of 8-aryl-2-morpholino-7-O-substituted benzo[e][1,3]oxazin-4-ones against DNA-PK, PI3K, PDE3A enzymes and platelet aggregation.
Bioorg Med Chem 25: 5531-5536 (2017)
La Trobe University
Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Bioorg Med Chem Lett 27: 4383-4388 (2017)
Seoul National University
Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c]pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators.
Bioorg Med Chem Lett 27: 4331-4335 (2017)
Sumitomo Dainippon Pharma
Design, synthesis, and biological activity of 5'-phenyl-1,2,5,6-tetrahydro-3,3'-bipyridine analogues as potential antagonists of nicotinic acetylcholine receptors.
Bioorg Med Chem Lett 27: 4350-4353 (2017)
University Of Michigan
Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and?-glucosidase.
Bioorg Med Chem Lett 27: 4309-4313 (2017)
Key Laboratory Of The Ministry Of Education For Medicinal Resources And Natural Pharmaceutical Chemistry
Development of GLUT4-selective antagonists for multiple myeloma therapy.
Eur J Med Chem 139: 573-586 (2017)
Emory University
Discovery of BAZ2A bromodomain ligands.
Eur J Med Chem 139: 564-572 (2017)
University Of Z£Rich
Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors.
ACS Chem Biol 12: 2399-2407 (2017)
University Of Delaware
1-Benzyl-3-aryl-2-thiohydantoin Derivatives as New Anti-
ACS Med Chem Lett 8: 886-891 (2017)
University Of Washington
Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.
ACS Med Chem Lett 8: 875-880 (2017)
Fudan University
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.
ACS Med Chem Lett 8: 869-874 (2017)
Celgene Quanticel Research
Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional Group.
ACS Med Chem Lett 8: 864-868 (2017)
University Of Pennsylvania
Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile.
ACS Med Chem Lett 8: 858-863 (2017)
Universit£
Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains.
ACS Med Chem Lett 8: 847-852 (2017)
Forma Therapeutics
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.
ACS Med Chem Lett 8: 841-846 (2017)
Wuxi Apptec (Shanghai)
Discovery of Potent and Selective A
ACS Med Chem Lett 8: 835-840 (2017)
Advinus Therapeutics
Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.
ACS Med Chem Lett 8: 830-834 (2017)
Chinese Academy Of Sciences
Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors.
ACS Med Chem Lett 8: 824-829 (2017)
University Of Illinois At Chicago
Structure-Guided Design and Initial Studies of a Bifunctional MEK/PI3K Inhibitor (ST-168).
ACS Med Chem Lett 8: 808-813 (2017)
University Of Michigan
-Acylbenzenesulfonamide Dihydro-1,3,4-oxadiazole Hybrids: Seeking Selectivity toward Carbonic Anhydrase Isoforms.
ACS Med Chem Lett 8: 792-796 (2017)
University Of Cagliari
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases.
ACS Med Chem Lett 8: 781-782 (2017)
Therachem Research Medilab (India)
Potential of PI3K? Inhibitors in the Treatment of Cancer and Other Diseases.
ACS Med Chem Lett 8: 778-780 (2017)
Therachem Research Medilab (India)
Plasma Kallikrein Inhibitors for the Treatment of Retinal Vascular Permeability Associated with Diabetic Retinopathy and Diabetic Macular Edema.
ACS Med Chem Lett 8: 776-777 (2017)
Therachem Research Medilab (India)
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-?-chloro-2'-?-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.
Bioorg Med Chem Lett 27: 4323-4330 (2017)
Idenix An Msd
Meroterpenoids with Protein Tyrosine Phosphatase 1B Inhibitory Activity from a Hyrtios sp. Marine Sponge.
J Nat Prod 80: 2509-2514 (2017)
Shenyang Pharmaceutical University
Design, Synthesis, and Biological Evaluation of Novel Type I
J Med Chem 60: 8027-8054 (2017)
Eberhard-Karls-Universitaet Tuebingen
Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model.
Bioorg Med Chem Lett 27: 4370-4376 (2017)
Genentech
Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
Eur J Med Chem 139: 531-541 (2017)
Hebei Medical University
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
J Med Chem 60: 7524-7538 (2017)
University Of Basel
Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.
Bioorg Med Chem Lett 27: 4221-4228 (2017)
Universidade De Santiago De Compostela
Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.
Bioorg Med Chem Lett 27: 4399-4404 (2017)
Korea Research Institute Of Chemical Technology
An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics.
Eur J Med Chem 139: 519-530 (2017)
University Of Calabria
Novel methyl indolinone-6-carboxylates containing an indole moiety as angiokinase inhibitors.
Eur J Med Chem 139: 492-502 (2017)
Shenyang Pharmaceutical University
Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
Eur J Med Chem 139: 482-491 (2017)
University Of Warwick
Highly Potent and Selective New Diphenethylamines Interacting with the?-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships.
J Med Chem 60: 7579-7590 (2017)
University Of Innsbruck
Antagonists of Orexin Receptors as Potential Treatment of Sleep Disorders, Obesity, Eating Disorders, and Other Neurological and Psychiatric Disorders.
ACS Med Chem Lett 7: 876-877 (2016)
Therachem Research Medilab (India)
Treatment of Metabolic Disorders with CB-1 Receptor Inverse Agonists.
ACS Med Chem Lett 7: 874-875 (2016)
Therachem Research Medilab (India)
An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.
Eur J Med Chem 139: 461-481 (2017)
Universidad Nacional De San Luis
Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts.
J Med Chem 61: 1767-1773 (2018)
Merck
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
J Med Chem 60: 7244-7255 (2017)
Emory Chemical Biology Discovery Center Emory University School Of Medicine Atlanta
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Eur J Med Chem 139: 429-440 (2017)
Wuhan University Of Science And Technology
Design, synthesis and in vivo study of novel pyrrolidine-based 11?-HSD1 inhibitors for age-related cognitive dysfunction.
Eur J Med Chem 139: 412-428 (2017)
Universitat De Barcelona
Discovery of non-zwitterionic aryl sulfonamides as Na
Bioorg Med Chem 25: 5490-5505 (2017)
Bristol-Myers Squibb Research And Development
Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis.
Bioorg Med Chem 26: 945-956 (2018)
Nestl�
Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity.
Bioorg Med Chem Lett 27: 4415-4420 (2017)
Beijing University Of Chemical Technology
Characterization of a highly selective inhibitor of the Aurora kinases.
Bioorg Med Chem Lett 27: 4405-4408 (2017)
Harvard Medical School
Identification of a New Zinc Binding Chemotype by Fragment Screening.
J Med Chem 60: 7333-7349 (2017)
Griffith University
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates.
J Med Chem 60: 7764-7780 (2017)
Pfizer
Notch Inhibitors from Calotropis gigantea That Induce Neuronal Differentiation of Neural Stem Cells.
J Nat Prod 80: 2453-2461 (2017)
Chiba University
Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.
J Med Chem 60: 7569-7578 (2017)
Ulsan National Institutes Of Science And Technology (Unist)
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Eur J Med Chem 142: 229-243 (2017)
Pak Research Center
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor.
J Med Chem 60: 8103-8114 (2017)
University Of Minnesota
Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase.
J Med Chem 60: 7539-7554 (2017)
The Institute Of Organic Chemistry And Biochemistry Of The Czech Academy Of Sciences
DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health.
J Nat Prod 80: 2284-2294 (2017)
Hallertauer Hopfenveredelung
A new chemotype inhibitor for the human organic cation transporter 3 (hOCT3).
Bioorg Med Chem Lett 27: 4440-4445 (2017)
Virginia Commonwealth University
Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.
Bioorg Med Chem Lett 27: 4421-4425 (2017)
University Of Ferrara
Structure-function studies of BPP-BrachyNH
Eur J Med Chem 139: 401-411 (2017)
Universidade Federal Do Piau£
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.
Eur J Med Chem 139: 378-389 (2017)
Alma Mater Studiorum-University Of Bologna
Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation.
Eur J Med Chem 139: 367-377 (2017)
Technology And Research University-Vfstru (Vignan's University)
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-?-lactamase-1.
J Med Chem 60: 7267-7283 (2017)
University Of California San Diego
Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.
Bioorg Med Chem 25: 5278-5289 (2017)
Chonnam National University
Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide.
Bioorg Med Chem 25: 5203-5215 (2017)
Taisho Pharmaceutical
Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A
J Med Chem 60: 7555-7568 (2017)
Leiden University
Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions.
Eur J Med Chem 142: 244-265 (2017)
Babasaheb Bhimrao Ambedkar University
Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
Eur J Med Chem 139: 325-336 (2017)
University Of Minnesota
Discovery of novel 3-(hydroxyalkoxy)-2-alkylchromen-4-one analogs as interleukin-5 inhibitors.
Eur J Med Chem 139: 290-304 (2017)
Chungnam National University
New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
Eur J Med Chem 139: 280-289 (2017)
Tehran University Of Medical Sciences
Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
Eur J Med Chem 139: 263-279 (2017)
King Abdulaziz University
1-Acetyl-5-phenyl-1H-pyrrol-3-ylacetate: An aldose reductase inhibitor for the treatment of diabetic nephropathy.
Bioorg Med Chem Lett 27: 4482-4487 (2017)
Shanghai Institute Of Pharmaceutical Industry
Discovery of potent and selective CDK8 inhibitors through FBDD approach.
Bioorg Med Chem Lett 27: 4488-4492 (2017)
Roche Innovation Center Shanghai
The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors.
Bioorg Med Chem Lett 27: 4500-4505 (2017)
H. Lundbeck
Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
Eur J Med Chem 139: 250-262 (2017)
Kafrelsheikh University
Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels.
Eur J Med Chem 139: 232-241 (2017)
University Of Ljubljana
Piperlongumine B and analogs are promising and selective inhibitors for acetylcholinesterase.
Eur J Med Chem 139: 222-231 (2017)
Martin-Luther University Halle-Wittenberg
Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Eur J Med Chem 139: 214-221 (2017)
Chinese Academy Of Sciences
Discovery of pentacyclic triterpene 3?-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
Eur J Med Chem 139: 201-213 (2017)
China Pharmaceutical University
Pyrrolo[2,1-f][1,2,4]triazines: From C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle.
Bioorg Med Chem Lett 27: 4238-4246 (2017)
Teva Global R&D
Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
Bioorg Med Chem 25: 5327-5340 (2017)
Glaxosmithkline
Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3K? inhibitors.
Eur J Med Chem 139: 95-106 (2017)
Shenyang Pharmaceutical University
Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Eur J Med Chem 139: 68-83 (2017)
China Pharmaceutical University
Quinoline hybrids and their antiplasmodial and antimalarial activities.
Eur J Med Chem 139: 22-47 (2017)
Hubei Engineering University
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
Eur J Med Chem 139: 153-167 (2017)
Universit£
Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation.
Eur J Med Chem 139: 128-152 (2017)
China Pharmaceutical University
Identification of 3,4-dihydro-2H-thiochromene 1,1-dioxide derivatives with a phenoxyethylamine group as highly potent and selective ?
Eur J Med Chem 139: 114-127 (2017)
Takeda Pharmaceutical
Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.
J Med Chem 61: 1415-1424 (2018)
Iota Pharmaceuticals
Drifting of heme-coordinating group in imidazolylmethylxanthones leading to improved selective inhibition of CYP11B1.
Eur J Med Chem 139: 60-67 (2017)
Alma Mater Studiorum-University Of Bologna
Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
Eur J Med Chem 139: 48-59 (2017)
Shanghai University Of Traditional Chinese Medicine
Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
Eur J Med Chem 139: 1-11 (2017)
Universidade De Vigo
Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian fungus of the family Cortinariaceae.
Bioorg Med Chem Lett 27: 4007-4010 (2017)
Griffith University
Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
Bioorg Med Chem 25: 5268-5277 (2017)
East China University Of Science & Technology
Biphenyloxy-alkyl-piperidine and azepane derivatives as histamine H
Bioorg Med Chem 25: 5341-5354 (2017)
Jagiellonian University Medical College
Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
Bioorg Med Chem 25: 5365-5372 (2017)
Universit£T M£Nster
Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders.
J Med Chem 60: 7677-7702 (2017)
Takeda Pharmaceutical
Direct Interaction of Chivosazole F with Actin Elicits Cell Responses Similar to Latrunculin A but Distinct from Chondramide.
ACS Chem Biol 12: 2264-2269 (2017)
Novartis Pharma
Identification and Characterization of the First Selective Y
J Med Chem 60: 7605-7612 (2017)
Leipzig University
Structural Basis of Analog Specificity in PKG I and II.
ACS Chem Biol 12: 2388-2398 (2017)
Baylor College Of Medicine
Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors.
J Med Chem 60: 7863-7875 (2017)
Moffitt Cancer Center
Effect of Nitrogen Atom Substitution in A
J Med Chem 60: 7502-7511 (2017)
Uppsala University
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.
J Med Chem 60: 7410-7424 (2017)
Research Triangle Institute
Facile alkylation of 4-nitrobenzotriazole and its platelet aggregation inhibitory activity.
Bioorg Med Chem 25: 5260-5267 (2017)
Punjabi University
Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties.
Bioorg Med Chem 25: 5373-5379 (2017)
Universit£
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Bioorg Med Chem 25: 5396-5406 (2017)
P.D. Patel Institute Of Applied Sciences
Imidazo[1,2-?]pyridines possess adenosine A
Bioorg Med Chem Lett 27: 3963-3967 (2017)
North-West University
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer.
J Med Chem 60: 7447-7458 (2017)
Universit£
Discovery of novel pyrazolo[1,5-a]pyridine-based EP
Bioorg Med Chem Lett 27: 4044-4050 (2017)
Kyorin Pharmaceutical
Targeting Eph/ephrin system in cancer therapy.
Eur J Med Chem 142: 152-162 (2017)
University Of Parma
Macrocyclic factor XIa inhibitors.
Bioorg Med Chem Lett 27: 4056-4060 (2017)
Bristol-Myers Squibb
Development of a highly reliable assay for ubiquitin-specific protease 2 inhibitors.
Bioorg Med Chem Lett 27: 4015-4018 (2017)
Shanghai Jiao Tong University
Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.
J Med Chem 60: 7146-7165 (2017)
Northwestern University
Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics.
Bioorg Med Chem 25: 4904-4916 (2017)
Xinjiang Technical Institute Of Physics And Chemistry
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors.
Bioorg Med Chem Lett 27: 4034-4038 (2017)
Neurodegeneration Dpu
A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects.
Eur J Med Chem 138: 1158-1169 (2017)
China Pharmaceutical University
Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors.
Eur J Med Chem 138: 1147-1157 (2017)
Roche Innovation Center Shanghai
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD).
J Med Chem 61: 1745-1766 (2018)
Universit£
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues.
J Med Chem 60: 7434-7446 (2017)
University Of Copenhagen
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models.
J Med Chem 60: 7099-7107 (2017)
Novartis Institutes For Biomedical Research
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
J Med Chem 61: 422-443 (2018)
Progenra
Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors.
Bioorg Med Chem Lett 27: 4051-4055 (2017)
Sichuan University And Collaborative Innovation Center
Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel?
Bioorg Med Chem 25: 4778-4799 (2017)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.
Eur J Med Chem 138: 1135-1146 (2017)
Tsinghua University
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
J Med Chem 60: 6911-6923 (2017)
University Of Messina
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.
J Med Chem 60: 7483-7501 (2017)
Jagiellonian University Medical College
Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors.
Bioorg Med Chem 25: 4855-4875 (2017)
Zarqa University
Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.
Bioorg Med Chem 25: 4876-4886 (2017)
Takeda Pharmaceutical
Recent advances (2015-2016) in anticancer hybrids.
Eur J Med Chem 142: 179-212 (2017)
University Of Kwazulu Natal
Structure-activity relations of rosmarinic acid derivatives for the amyloid ? aggregation inhibition and antioxidant properties.
Eur J Med Chem 138: 1066-1075 (2017)
Muroran Institute Of Technology
Thienopyrimidine derivatives exert their anticancer efficacy via apoptosis induction, oxidative stress and mitotic catastrophe.
Eur J Med Chem 138: 1053-1065 (2017)
University Of Toledo
An overview of benzo[b]thiophene-based medicinal chemistry.
Eur J Med Chem 138: 1002-1033 (2017)
Jain University
Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides.
J Med Chem 60: 7123-7138 (2017)
Abbvie Deutschland
Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders.
J Med Chem 60: 7658-7676 (2017)
Takeda Pharmaceutical
Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain.
J Med Chem 60: 7799-7809 (2017)
Academy Of Sciences Of The Czech Republic
Design, synthesis and bioactivities of Celecoxib analogues or derivatives.
Bioorg Med Chem 25: 4887-4893 (2017)
Chongqing Normal University
ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.
Bioorg Med Chem Lett 27: 4082-4085 (2017)
University Of Arizona
Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5?-androst-17?-amide derivatives as dual 5?-reductase inhibitors and androgen receptor antagonists.
Bioorg Med Chem Lett 27: 4212-4217 (2017)
China Pharmaceutical University
Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Eur J Med Chem 138: 979-992 (2017)
Southeast University
Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands.
Eur J Med Chem 138: 964-978 (2017)
Universities Of Lille
Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor.
Bioorg Med Chem 25: 4817-4828 (2017)
Daiichi Sankyo
Structure-based design, synthesis, and evaluation of 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel c-Met inhibitors.
Eur J Med Chem 138: 942-951 (2017)
China Pharmaceutical University
How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors.
Eur J Med Chem 142: 131-151 (2017)
Ain Shams University
Discovery of orally bioavailable cyclohexanol-based NR2B-selective NMDA receptor antagonists with analgesic activity utilizing a scaffold hopping approach.
Bioorg Med Chem Lett 27: 4194-4198 (2017)
Shionogi
Anion inhibitors of the?-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella tularensis.
Bioorg Med Chem 25: 4800-4804 (2017)
Cnr
Neuroactive Steroids. 2. 3?-Hydroxy-3?-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5?-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (?-Aminobutyric Acid)
J Med Chem 60: 7810-7819 (2017)
Sage Therapeutics
Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
J Med Chem 60: 7206-7212 (2017)
University Of Porto
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study.
J Nat Prod 80: 2276-2283 (2017)
Universit£
?-Geminal disubstituted pyrrolidine iminosugars and their C-4-fluoro analogues: Synthesis, glycosidase inhibition and molecular docking studies.
Bioorg Med Chem 25: 5148-5159 (2017)
Savitribai Phule Pune University (Formerly University Of Pune)
Discovery of spiro[indole-3,2'-pyrrolidin]-2(1H)-one based inhibitors targeting Brr2, a core component of the U5 snRNP.
Bioorg Med Chem 25: 4753-4767 (2017)
Takeda Pharmaceutical
Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.
Bioorg Med Chem Lett 27: 4180-4184 (2017)
Central South University
Synthesis of 2-imino and 2-hydrazono thiazolo[4,5-d]pyrimidines as corticotropin releasing factor (CRF) antagonists.
Eur J Med Chem 138: 900-908 (2017)
South Dakota State University
Nonacidic Farnesoid X Receptor Modulators.
J Med Chem 60: 7199-7205 (2017)
Goethe-University Frankfurt
Bioactive Azaphilone Derivatives from the Fungus Talaromyces aculeatus.
J Nat Prod 80: 2199-2203 (2017)
Hebei University
BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease.
J Med Chem 61: 619-637 (2018)
University Of Dundee
Microbiota-Host Transgenomic Metabolism, Bioactive Molecules from the Inside.
J Med Chem 61: 47-61 (2018)
University Of Bologna
Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products.
J Nat Prod 80: 2360-2370 (2017)
University Of The Philippines
Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide.
J Med Chem 60: 7166-7185 (2017)
Shandong University
Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors.
Bioorg Med Chem Lett 27: 4156-4164 (2017)
Chungnam National University
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists.
J Med Chem 60: 6548-6562 (2017)
Universit£
Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor.
ACS Med Chem Lett 8: 771-774 (2017)
Bristol-Myers Squibb Research And Development
3-Hydroxykynurenine, a Tryptophan Metabolite Generated during the Infection, Is Active Against
ACS Med Chem Lett 8: 757-761 (2017)
Universidad Nacional De C£Rdoba
Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural Modification.
ACS Med Chem Lett 8: 751-756 (2017)
Tokyo University Of Pharmacy And Life Sciences
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2).
ACS Med Chem Lett 8: 737-741 (2017)
Genentech
Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.
ACS Med Chem Lett 8: 732-736 (2017)
Takeda Pharmaceutical
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.
ACS Med Chem Lett 8: 726-731 (2017)
Sanford Burnham Prebys Medical Discovery Institute
Identification of a Novel TRPM8 Agonist from Nutmeg: A Promising Cooling Compound.
ACS Med Chem Lett 8: 715-719 (2017)
Kao
Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor.
ACS Med Chem Lett 8: 694-700 (2017)
The Scripps Research Institute
Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors.
Bioorg Med Chem 25: 4579-4594 (2017)
Fudan University
Discovery of a low-systemic-exposure DGAT-1 inhibitor with a picolinoylpyrrolidine-2-carboxylic acid moiety.
Bioorg Med Chem 25: 4701-4714 (2017)
Xinxiang Medical University
Essential structure of orexin 1 receptor antagonist YNT-707, Part I: Role of the 4,5-epoxy ring for binding with orexin 1 receptor.
Bioorg Med Chem Lett 27: 4176-4179 (2017)
University Of Tsukuba
Pocket detection and interaction-weighted ligand-similarity search yields novel high-affinity binders for Myocilin-OLF, a protein implicated in glaucoma.
Bioorg Med Chem Lett 27: 4133-4139 (2017)
Georgia Institute Of Technology
Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors.
Eur J Med Chem 138: 874-883 (2017)
Jagiellonian University Medical College
Inhibitory Kappa B Kinase? (IKK?) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers.
J Med Chem 60: 7043-7066 (2017)
University Of Strathclyde
Indazole-based ligands for estrogen-related receptor ? as potential anti-diabetic agents.
Eur J Med Chem 138: 830-853 (2017)
Janssen Research And Development
Chemoselective synthesis and biological evaluation of arylated 2-(Trifluoromethyl) quinolines as nucleotide pyrophosphatase (NPPs) inhibitors.
Eur J Med Chem 138: 816-829 (2017)
Universit£T Rostock
Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
Bioorg Med Chem 25: 4745-4752 (2017)
University Of Catania
Discovery of (R)-5-(benzo[d][1,3]dioxol-5-yl)-7-((1-(vinylsulfonyl)pyrrolidin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (B6) as a potent Bmx inhibitor for the treatment of NSCLC.
Bioorg Med Chem Lett 27: 4171-4175 (2017)
Sichuan University And Collaborative Innovation Center
Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.
Eur J Med Chem 138: 774-806 (2017)
The Medical University Of Silesia
Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.
J Med Chem 60: 7371-7392 (2017)
Galapagos
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
J Med Chem 61: 2133-2165 (2018)
Biocon Bristol-Myers Squibb R&D Centre
Neuropathic pain-alleviating effects of pyrazole-conjugated arylsulfonamides as 5-HT
Bioorg Med Chem Lett 27: 4146-4149 (2017)
University Of Science And Technology
KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
Bioorg Med Chem 25: 4628-4636 (2017)
Universidad De La Habana
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads.
Bioorg Med Chem 25: 4560-4565 (2017)
Universita Degli Studi Di Firenze
New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
Eur J Med Chem 138: 761-773 (2017)
Universidad De Sevilla
Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
Eur J Med Chem 138: 748-760 (2017)
National And Kapodistrian University Of Athens
Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
Eur J Med Chem 138: 738-747 (2017)
Central South University
Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.
Eur J Med Chem 138: 729-737 (2017)
University Of Tehran
Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-? aggregation for the treatment of Alzheimer's disease.
Eur J Med Chem 138: 715-728 (2017)
Shenyang Pharmaceutical University
Opioid Receptor Modulators with a Cinnamyl Group.
J Med Chem 60: 6733-6750 (2017)
Alkem Laboratories
Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis.
J Med Chem 60: 7067-7083 (2017)
East China Normal University
Mushroom-Derived Indole Alkaloids.
J Nat Prod 80: 2178-2187 (2017)
University Of Auckland
Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Bioorg Med Chem Lett 27: 3653-3660 (2017)
Nanjing University
Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis.
Bioorg Med Chem Lett 27: 3939-3943 (2017)
Merck
Synthesis and biological evaluation of fluoro-substituted 3,4-dihydroquinazoline derivatives for cytotoxic and analgesic effects.
Bioorg Med Chem 25: 4656-4664 (2017)
Kyung Hee University
Recent synthetic and medicinal perspectives of tryptanthrin.
Bioorg Med Chem 25: 4533-4552 (2017)
Indo-Soviet Friendship College Of Pharmacy (Isfcp)
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPAR? and SUR agonists.
Bioorg Med Chem 25: 4723-4744 (2017)
Al-Azhar University
Asymmetric synthesis and evaluation of epoxy-?-acyloxycarboxamides as selective inhibitors of cathepsin L.
Bioorg Med Chem 25: 4620-4627 (2017)
Federal University Of S£O Carlos
Synthesis and diabetic neuropathic pain-alleviating effects of 2N-(pyrazol-3-yl)methylbenzo[d]isothiazole-1,1-dioxide derivatives.
Bioorg Med Chem 25: 4677-4685 (2017)
Korea University Of Science And Technology (Ust)
Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.
ACS Chem Biol 12: 2240-2247 (2017)
Michigan State University
Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene.
J Nat Prod 80: 2094-2100 (2017)
Istanbul Technical University
Synthesis and evaluation of osimertinib derivatives as potent EGFR inhibitors.
Bioorg Med Chem 25: 4553-4559 (2017)
Tsinghua University-Peking University Joint Center For Life Sciences
Design, synthesis and biological evaluation of novel 4-phenoxyquinoline derivatives containing 3-oxo-3,4-dihydroquinoxaline moiety as c-Met kinase inhibitors.
Bioorg Med Chem 25: 4475-4486 (2017)
Shenyang Pharmaceutical University
Probing the Hydrophobic Binding Pocket of G-Protein-Coupled Lysophosphatidylserine Receptor GPR34/LPS
J Med Chem 60: 6384-6399 (2017)
The University Of Tokyo
Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer.
J Med Chem 60: 6018-6035 (2017)
University Of Chinese Academy Of Sciences
Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
J Med Chem 60: 6924-6941 (2017)
Sun Yat-Sen University
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.
J Med Chem 60: 6998-7011 (2017)
University College London
Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine.
Bioorg Med Chem 25: 5128-5132 (2017)
Purdue University
Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3? inhibitors.
Bioorg Med Chem Lett 27: 3726-3732 (2017)
Mitsubishi Tanabe Pharma
Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3? inhibitors.
Bioorg Med Chem Lett 27: 3733-3738 (2017)
Mitsubishi Tanabe Pharma
The Fragment Network: A Chemistry Recommendation Engine Built Using a Graph Database.
J Med Chem 60: 6440-6450 (2017)
Astex Pharmaceuticals
Novel 4-arylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells.
Eur J Med Chem 138: 689-697 (2017)
Shaanxi Normal University
Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Eur J Med Chem 138: 669-688 (2017)
Beijing Normal University
Development of a prodrug of hydantoin based TACE inhibitor.
Bioorg Med Chem Lett 27: 3704-3708 (2017)
Merck
Discovery of dual Axl/VEGF-R2 inhibitors as potential anti-angiogenic and anti-metastatic drugs for cancer chemotherapy.
Bioorg Med Chem Lett 27: 3766-3771 (2017)
Rigel Pharmaceuticals
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.
Bioorg Med Chem Lett 27: 3683-3687 (2017)
De Montfort University
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6).
Eur J Med Chem 138: 661-668 (2017)
Thomas Jefferson University
Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification.
Eur J Med Chem 138: 644-660 (2017)
Universidad De Sevilla
Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors.
Bioorg Med Chem Lett 27: 3749-3754 (2017)
Birla Institute Of Technology
Novel pyrazolopyrimidines: Synthesis, in vitro cytotoxic activity and mechanistic investigation.
Eur J Med Chem 138: 565-576 (2017)
Cairo University
Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.
Eur J Med Chem 138: 552-564 (2017)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity.
Eur J Med Chem 138: 543-551 (2017)
Shandong University
Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.
J Med Chem 60: 6704-6720 (2017)
Leiden University
Phylogenomics of 2,4-Diacetylphloroglucinol-Producing Pseudomonas and Novel Antiglycation Endophytes from Piper auritum.
J Nat Prod 80: 1955-1963 (2017)
Unidad De Gen�Mica Avanzada (Langebio)
Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease.
J Med Chem 60: 6664-6677 (2017)
Shenzhen University
Combining Elements from Two Antagonists of Formyl Peptide Receptor 2 Generates More Potent Peptidomimetic Antagonists.
J Med Chem 60: 6991-6997 (2017)
University Of Copenhagen
Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure.
J Med Chem 60: 6942-6990 (2017)
Takeda Pharmaceutical
Bistacrines as potential antitrypanosomal agents.
Bioorg Med Chem 25: 4526-4531 (2017)
Julius-Maximilians-University Of W£Rzburg
Stable C-N axial chirality in 1-aryluracil scaffold and differences in in vitro metabolic clearance between atropisomers of PDE4 inhibitor.
Bioorg Med Chem 25: 4506-4511 (2017)
Osaka University
Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.
J Med Chem 60: 6721-6732 (2017)
University Of California
Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
J Med Chem 60: 6451-6457 (2017)
Pfizer
Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from?-Santonin Derivatives.
J Med Chem 60: 6828-6852 (2017)
Second Military Medical University
Discovery of a Benzamide Derivative That Protects Pancreatic?-Cells against Endoplasmic Reticulum Stress.
J Med Chem 60: 6191-6204 (2017)
Oklahoma Medical Research Foundation
Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors.
Bioorg Med Chem Lett 27: 3812-3816 (2017)
China Medical University
Tuning of ?-glucosidase and ?-galactosidase inhibition by generation and in situ screening of a library of pyrrolidine-triazole hybrid molecules.
Eur J Med Chem 138: 532-542 (2017)
University Of Seville
Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy.
Eur J Med Chem 138: 514-531 (2017)
East China University Of Science And Technology
Triazole derivatives and their anti-tubercular activity.
Eur J Med Chem 138: 501-513 (2017)
Wuhan University Of Science And Technology
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1.
J Med Chem 61: 583-598 (2018)
Arvinas
Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers.
J Med Chem 60: 6337-6352 (2017)
Sichuan University And Collaborative Innovation Center For Biotherapy
Constituents of Polygala flavescens ssp. flavescens and Their Activity as Inhibitors of Human Lactate Dehydrogenase.
J Nat Prod 80: 2077-2087 (2017)
Universit£
Design and synthesis of potent and orally active GPR4 antagonists with modulatory effects on nociception, inflammation, and angiogenesis.
Bioorg Med Chem 25: 4512-4525 (2017)
Novartis Institutes For Biomedical Research
The medicinal chemistry of Chikungunya virus.
Bioorg Med Chem 25: 4219-4244 (2017)
Federal University Of Alagoas
Selective inhibitors of human mPGES-1 from structure-based computational screening.
Bioorg Med Chem Lett 27: 3739-3743 (2017)
University Of Kentucky
Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
Eur J Med Chem 138: 458-479 (2017)
China Pharmaceutical University
First dual AK/GSK-3? inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.
Eur J Med Chem 138: 438-457 (2017)
Universit£
Discovery of highly selective?-opioid receptor agonists: 10?-Hydroxy TRK-820 derivatives.
Bioorg Med Chem Lett 27: 3920-3924 (2017)
Toray Industries
Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector.
Eur J Med Chem 138: 407-421 (2017)
Emory University
Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Eur J Med Chem 138: 396-406 (2017)
University Of The Punjab
Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues.
Eur J Med Chem 138: 371-383 (2017)
Universit£
Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase.
Eur J Med Chem 138: 343-352 (2017)
Peking University Health Science Center
Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents.
Eur J Med Chem 138: 328-342 (2017)
Centro De Investigaciones Biol�Gicas-Csic
Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines.
Bioorg Med Chem Lett 27: 3897-3904 (2017)
Karolinska Institutet
Oxindole-based intraocular pressure reducing agents.
Bioorg Med Chem Lett 27: 3787-3793 (2017)
Lomonosov Moscow State University
Optimization of 1H-indazol-3-amine derivatives as potent fibroblast growth factor receptor inhibitors.
Bioorg Med Chem Lett 27: 3782-3786 (2017)
Fudan University
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency.
Bioorg Med Chem Lett 27: 3833-3839 (2017)
Bristol-Myers Squibb
Antiproliferative and apoptotic activities of sequence-specific histone acetyltransferase inhibitors.
Eur J Med Chem 138: 320-327 (2017)
Kyoto University
Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension.
J Med Chem 60: 6622-6637 (2017)
Sun Yat-Sen University
Identification of Peptidic Antagonists of Vascular Endothelial Growth Factor Receptor 1 by Scanning the Binding Epitopes of Its Ligands.
J Med Chem 60: 6598-6606 (2017)
Umr 8638 Cnrs
Synthetic Modification within the"RPRL" Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation.
J Med Chem 60: 6408-6427 (2017)
University Of Alberta
Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.
Bioorg Med Chem Lett 27: 3829-3832 (2017)
Takeda Pharmaceutical
Discovery of a biarylamide series of potent, state-dependent Na
Bioorg Med Chem Lett 27: 3817-3824 (2017)
Amgen
Conjugates of salicylaldoximes and peripheral site ligands: Novel efficient nonquaternary reactivators for nerve agent-inhibited acetylcholinesterase.
Bioorg Med Chem 25: 4497-4505 (2017)
Fourth Military Medical University
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na
J Med Chem 60: 7029-7042 (2017)
Icagen
Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis.
Bioorg Med Chem Lett 27: 3806-3811 (2017)
University Of Mysore
Substituted?-mercaptoketones, new types of specific neprilysin inhibitors.
Bioorg Med Chem Lett 27: 3883-3890 (2017)
Pharmaleads
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
Eur J Med Chem 138: 273-292 (2017)
Csir - Indian Institute Of Integrative Medicine
Design, synthesis and biological evaluation of GPR55 agonists.
Bioorg Med Chem 25: 4355-4367 (2017)
University Of North Carolina At Greensboro
Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B.
J Med Chem 60: 6137-6151 (2017)
Janssen Pharmaceutica
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
J Med Chem 60: 6563-6586 (2017)
Universit£
Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors.
J Med Chem 60: 6678-6692 (2017)
Experimental Therapeutics Centre
Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Bioorg Med Chem 25: 4424-4432 (2017)
Banaras Hindu University
Interconvertible geometric isomers of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modes.
Bioorg Med Chem Lett 27: 3878-3882 (2017)
University Of Leeds
Synthesis and evaluation of (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate derivatives as HCA2 receptor agonists.
Bioorg Med Chem 25: 4314-4329 (2017)
Latvian Institute Of Organic Synthesis
Diaminopimelic acid (DAP) analogs bearing isoxazoline moiety as selective inhibitors against meso-diaminopimelate dehydrogenase (m-Ddh) from Porphyromonas gingivalis.
Bioorg Med Chem Lett 27: 3840-3844 (2017)
Virginia Commonwealth University
A novel structural class of coumarin-chalcone fibrates as PPAR?/? agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies.
Eur J Med Chem 138: 212-220 (2017)
Shenyang Pharmaceutical University
Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches.
Eur J Med Chem 138: 199-211 (2017)
China Pharmaceutical University
Recent developments in biological activities of indanones.
Eur J Med Chem 138: 182-198 (2017)
Jain University
Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.
Bioorg Med Chem 25: 5084-5094 (2017)
Friedrich-Alexander University Erlangen-N£Rnberg
Design, synthesis, and biological evaluation of aryl N-methoxyamide derivatives as GPR119 agonists.
Bioorg Med Chem Lett 27: 3909-3914 (2017)
Korea Research Institute Of Chemical Technology
Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors.
J Med Chem 60: 6516-6527 (2017)
Principia Biopharma
Antitrichomonal activity of? opioid receptor antagonists, 7-benzylidenenaltrexone derivatives.
Bioorg Med Chem 25: 4375-4383 (2017)
University Of Tsukuba
Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Bioorg Med Chem 25: 4259-4264 (2017)
Riken Center For Life Science Technologies
Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.
Bioorg Med Chem 25: 4414-4423 (2017)
Icahn School Of Medicine At Mount Sinai
Novel 3H-[1,2,3]triazolo[4,5-c]pyridine derivatives as GPR119 agonists: Synthesis and structure-activity/solubility relationships.
Bioorg Med Chem 25: 4339-4354 (2017)
Taisho Pharmaceutical
Discovery and development of a novel class of phenoxyacetyl amides as highly potent TRPM8 agonists for use as cooling agents.
Bioorg Med Chem Lett 27: 3931-3938 (2017)
Senomyx
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold To Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII.
J Med Chem 60: 6428-6439 (2017)
Universit£
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.
J Med Chem 60: 6273-6288 (2017)
University Of Illinois At Chicago
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.
J Med Chem 60: 6321-6336 (2017)
The Scripps Research Institute
Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.
J Med Chem 60: 6089-6097 (2017)
Takeda Pharmaceutical
Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization.
J Med Chem 60: 6249-6272 (2017)
University Of Nantes
Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.
J Med Chem 60: 5364-5376 (2017)
Purdue University
Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems.
Bioorg Med Chem Lett 27: 3219-3225 (2017)
Karolinska Institutet
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Bioorg Med Chem Lett 27: 3602-3606 (2017)
Guangxi Medical University
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
J Med Chem 60: 9413-9436 (2017)
University Of Valencia
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors.
J Med Chem 60: 5816-5825 (2017)
Scripps Florida
Glucuronides as Potential Anionic Substrates of Human Cytochrome P450 2C8 (CYP2C8).
J Med Chem 60: 8691-8705 (2017)
Celgene
3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.
J Med Chem 60: 6036-6044 (2017)
Heinrich-Heine-Universit£T D£Sseldorf
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.
Bioorg Med Chem Lett 27: 3243-3248 (2017)
Viamet Pharmaceuticals
Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase.
Bioorg Med Chem Lett 27: 3607-3610 (2017)
University Of Namur
Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate.
Bioorg Med Chem Lett 27: 3231-3237 (2017)
Nankai University
Novel analogs of N-acylhydroxyethylaminomethyl-4H-chromen-4-one scaffold as IL-5 inhibitors.
Bioorg Med Chem 25: 4330-4338 (2017)
Chungnam National University
Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies.
Eur J Med Chem 137: 598-611 (2017)
Zhejiang University
Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.
J Med Chem 60: 6289-6304 (2017)
Shandong University
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
J Med Chem 60: 6305-6320 (2017)
Universit£
Optimization of a novel series of potent and orally bioavailable GPR119 agonists.
Bioorg Med Chem Lett 27: 3249-3253 (2017)
Kowa
Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: Screening with iPSC-derived neuronal cells.
Bioorg Med Chem Lett 27: 3289-3293 (2017)
The Scripps Research Institute
The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
Bioorg Med Chem Lett 27: 3254-3258 (2017)
Wayne State University
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
Bioorg Med Chem 25: 4194-4202 (2017)
China Pharmaceutical University
Thiophene/thiazole-benzene replacement on guanidine derivatives targeting?
Eur J Med Chem 138: 38-50 (2017)
Trinity College
Designing novel inhibitors against histone acetyltransferase (HAT: GCN5) of Plasmodium falciparum.
Eur J Med Chem 138: 26-37 (2017)
Jawaharlal Nehru University
Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists.
Bioorg Med Chem Lett 27: 3272-3278 (2017)
Janssen Research And Development
Varic acid analogues from fungus as PTP1B inhibitors: Biological evaluation and structure-activity relationships.
Bioorg Med Chem Lett 27: 3382-3385 (2017)
Dalian University Of Technology
Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus.
Bioorg Med Chem 25: 4175-4193 (2017)
Scohia Pharma
Synthesis of 8-Substituted Analogues of Cyclic ADP-4-Thioribose and Their Unexpected Identification as Ca
J Med Chem 60: 5868-5875 (2017)
Juntendo University School Of Medicine
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.
J Med Chem 60: 6364-6383 (2017)
National Institute Of Diabetes And Digestive And Kidney Diseases
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT
J Med Chem 60: 6166-6190 (2017)
Bristol-Myers Squibb
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Bioorg Med Chem 25: 4064-4075 (2017)
P.D. Patel Institute Of Applied Sciences
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors.
Bioorg Med Chem 25: 4031-4044 (2017)
Peking University
Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase.
Bioorg Med Chem Lett 27: 3294-3300 (2017)
Bristol-Myers Squibb Research And Development
Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.
Bioorg Med Chem Lett 27: 3576-3581 (2017)
Vanderbilt University School Of Medicine
Design, synthesis and biological evaluation of novel 3H-imidazole [4,5-b] pyridine derivatives as selective mTOR inhibitors.
Bioorg Med Chem Lett 27: 3395-3398 (2017)
China Pharmaceutical University
Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors.
Bioorg Med Chem 25: 4123-4132 (2017)
Shandong University
A novel intestinal-restricted FXR agonist.
Bioorg Med Chem Lett 27: 3386-3390 (2017)
China Pharmaceutical University
The discovery of benzoxazine sulfonamide inhibitors of Na
Bioorg Med Chem Lett 27: 3477-3485 (2017)
Amgen
Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors.
Eur J Med Chem 137: 545-557 (2017)
University Of Science And Technology Of China
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
J Med Chem 60: 6528-6547 (2017)
Sapienza University Of Rome
Development of Quinazoline/Pyrimidine-2,4(1
ACS Med Chem Lett 8: 678-681 (2017)
Zhejiang University
Discovery of a Series of Indazole TRPA1 Antagonists.
ACS Med Chem Lett 8: 666-671 (2017)
Pfizer
Photoaffinity Labeling of the Human A
ACS Med Chem Lett 8: 660-665 (2017)
Kissei Pharmaceutical
Exploitation of Conformational Dynamics in Imparting Selective Inhibition for Related Matrix Metalloproteinases.
ACS Med Chem Lett 8: 654-659 (2017)
University Of Notre Dame
Systematic Data Mining Reveals Synergistic H3R/MCHR1 Ligands.
ACS Med Chem Lett 8: 648-653 (2017)
Freie Universit£T Berlin
F-NMR-Based Dual-Site Reporter Assay for the Discovery and Distinction of Catalytic and Allosteric Kinase Inhibitors.
ACS Med Chem Lett 8: 632-635 (2017)
Novartis Institutes For Biomedical Research
Antiobesity Effect of a Short-Length Peptide YY Analogue after Continuous Administration in Mice.
ACS Med Chem Lett 8: 628-631 (2017)
Takeda Pharmaceutical
Identification and Characterization of JAK2 Pseudokinase Domain Small Molecule Binders.
ACS Med Chem Lett 8: 618-621 (2017)
Yale University
JAK2 JH2 Fluorescence Polarization Assay and Crystal Structures for Complexes with Three Small Molecules.
ACS Med Chem Lett 8: 614-617 (2017)
Yale University
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.
ACS Med Chem Lett 8: 608-613 (2017)
Genentech
Janus-Associated Kinase 1 (JAK1) Inhibitors as Potential Treatment for Immune Disorders.
ACS Med Chem Lett 8: 598-600 (2017)
Therachem Research Medilab (India)
Inhibitors of Adaptor-Associated Kinase 1 (AAK1) May Treat Neuropathic Pain, Schizophrenia, Parkinson's Disease, and Other Disorders.
ACS Med Chem Lett 8: 595-597 (2017)
Therachem Research Medilab (India)
Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors.
Bioorg Med Chem 25: 4145-4152 (2017)
Seoul National University
Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22.
Eur J Med Chem 137: 476-487 (2017)
The Australian Nuclear Science And Technology Organisation
2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
Eur J Med Chem 137: 462-475 (2017)
Peking University Health Science Center
A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.
Bioorg Med Chem Lett 27: 3349-3352 (2017)
Leipzig University
Anti-diabetic xanthones from the bark of Garcinia xanthochymus.
Bioorg Med Chem Lett 27: 3301-3304 (2017)
Vnuhcm-University Of Science
Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors.
Bioorg Med Chem 25: 4045-4054 (2017)
Chinese Academy Of Medical Sciences & Peking Union Medical College
Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: Pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition.
Bioorg Med Chem 25: 4153-4162 (2017)
Takeda Pharmaceutical
Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines.
J Nat Prod 80: 1992-2000 (2017)
University Of Iowa
Sulawesins A-C, Furanosesterterpene Tetronic Acids That Inhibit USP7, from a Psammocinia sp. Marine Sponge.
J Nat Prod 80: 2045-2050 (2017)
Kumamoto University
Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo.
J Med Chem 60: 5717-5735 (2017)
Novartis Pharma
Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.
Bioorg Med Chem Lett 27: 3511-3515 (2017)
Fudan University
Design, synthesis, and evaluation of DNA topoisomerase II-targeted nucleosides.
Bioorg Med Chem 25: 4133-4144 (2017)
Kyoto University
Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.
Eur J Med Chem 142: 74-86 (2017)
Universit£
Structure-activity relationship study and optimisation of 2-aminopyrrole-1-benzyl-4,5-diphenyl-1H-pyrrole-3-carbonitrile as a broad spectrum metallo-?-lactamase inhibitor.
Eur J Med Chem 137: 351-364 (2017)
The University Of Queensland
A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose.
J Med Chem 60: 5933-5939 (2017)
Eli Lilly
Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38? MAPK/PDE-4 Inhibitor with Activity against TNF?-Related Diseases.
J Med Chem 60: 5290-5305 (2017)
C-A-I-R Biosciences
Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1.
J Med Chem 60: 5857-5867 (2017)
Jagiellonian University
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a"Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
J Med Chem 60: 5909-5926 (2017)
Vfp Therapies
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT).
Bioorg Med Chem Lett 27: 3317-3325 (2017)
Abbvie
Design and synthesis of a novel inhibitor of T. Viride chitinase through an in silico target fishing protocol.
Bioorg Med Chem Lett 27: 3332-3336 (2017)
University Of Siena
Synthesis, potential anti-inflammatory and analgesic activities study of (S)-N-substituted-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxamides.
Bioorg Med Chem Lett 27: 3378-3381 (2017)
Zhejiang Ocean University Engineering Technology Research Center Of Marine Biomedical Products
3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
Bioorg Med Chem Lett 27: 3521-3528 (2017)
Zhengzhou University
Synthesis and biological evaluation of steroidal derivatives bearing a small ring as vitamin D receptor agonists.
Bioorg Med Chem Lett 27: 3408-3411 (2017)
Kyoto University
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
Bioorg Med Chem Lett 27: 3353-3358 (2017)
Pfizer
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments.
Eur J Med Chem 137: 327-337 (2017)
Universit£
Anti-diabetic activity of fused PPAR?-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.
Eur J Med Chem 137: 310-326 (2017)
University Of Lille
Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.
J Med Chem 60: 5599-5612 (2017)
National Health Research Institutes
Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies.
J Med Chem 60: 9913-9931 (2017)
Universit£
Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors.
Bioorg Med Chem Lett 27: 3207-3218 (2017)
Amgen
Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii.
Eur J Med Chem 137: 280-291 (2017)
Tianjin University Of Technology
Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site.
J Med Chem 60: 5613-5637 (2017)
Eberhard Karls University T£Bingen
a-Conotoxin [S9A]TxID Potently Discriminates betweena3ß4 anda6/a3ß4 Nicotinic Acetylcholine Receptors.
J Med Chem 60: 5826-5833 (2017)
Hainan University
Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells.
J Med Chem 60: 5800-5815 (2017)
Istituto Italiano Di Tecnologia
Design and synthesis of novel? opioid receptor agonists with an azatricyclodecane skeleton for improving blood-brain barrier penetration.
Bioorg Med Chem Lett 27: 3495-3498 (2017)
Nippon Chemiphar
Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.
Bioorg Med Chem 25: 4076-4087 (2017)
Cardiff University
Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs.
Bioorg Med Chem 25: 4008-4030 (2017)
The Institute Of Organic Chemistry And Biochemistry Of The Czech Academy Of Sciences
Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy.
Bioorg Med Chem 25: 4100-4109 (2017)
Tsinghua University
Design, synthesis and biological evaluation of renin inhibitors guided by simulated annealing of chemical potential simulations.
Bioorg Med Chem 25: 3947-3963 (2017)
Bioleap
Synthesis and pharmacological evaluation of glycine amide derivatives as novel vascular adhesion protein-1 inhibitors without CYP3A4 and CYP2C19 inhibition.
Bioorg Med Chem 25: 4110-4122 (2017)
Astellas Pharma
A new type of pharmacological chaperone for G
Bioorg Med Chem Lett 27: 3431-3435 (2017)
Graz University Of Technology
Design and Synthesis of?- and?-Lactam M
J Med Chem 60: 6649-6663 (2017)
Pfizer
A potent and selective natriuretic peptide receptor-3 blocker 11-mer peptide created by hybridization of musclin and atrial natriuretic peptide.
Bioorg Med Chem Lett 27: 3542-3545 (2017)
Takeda Pharmaceutical
2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.
J Med Chem 60: 5424-5437 (2017)
Emory University
Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds.
J Med Chem 61: 504-513 (2018)
University Of Dundee
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands.
J Med Chem 61: 543-575 (2018)
National Institute Of Health Sciences
1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction.
J Med Chem 60: 5663-5672 (2017)
Takeda California
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.
J Med Chem 60: 8268-8297 (2017)
Universit£
Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines.
J Med Chem 60: 5455-5471 (2017)
Glaxosmithkline
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A
J Med Chem 60: 5772-5790 (2017)
Universit£
Synthesis, docking study and neuroprotective effects of some novel pyrano[3,2-c]chromene derivatives bearing morpholine/phenylpiperazine moiety.
Bioorg Med Chem 25: 3980-3988 (2017)
Tehran University Of Medical Sciences
Compounds Interfering with Embryonic Lethal Abnormal Vision (ELAV) Protein-RNA Complexes: An Avenue for Discovering New Drugs.
J Med Chem 60: 8257-8267 (2017)
University Of Pavia
Insights on the Interaction between Transthyretin and A? in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal.
J Med Chem 60: 5749-5758 (2017)
Cic Biogune
Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor.
Eur J Med Chem 137: 176-195 (2017)
Chinese Academy Of Sciences
The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
J Med Chem 60: 5556-5585 (2017)
Emory University
Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.
J Med Chem 60: 5759-5771 (2017)
Takeda California
Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-? Motif Kinase (ZAK) Inhibitors.
J Med Chem 60: 5927-5932 (2017)
University Of Macau
Substituted arylsulphonamides as inhibitors of perforin-mediated lysis.
Eur J Med Chem 137: 139-155 (2017)
University Of Auckland
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines.
J Med Chem 60: 5334-5348 (2017)
Heinrich-Heine-Universit£T D£Sseldorf
Design, synthesis, in silico and in vitro evaluation of thiophene derivatives: A potent tyrosine phosphatase 1B inhibitor and anticancer activity.
Bioorg Med Chem Lett 27: 3558-3564 (2017)
K L University
Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554.
Bioorg Med Chem Lett 27: 3565-3571 (2017)
Takeda Pharmaceutical
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
Bioorg Med Chem 25: 3997-4007 (2017)
Urals Branch Of Russian Academy Of Sciences
BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium.
Bioorg Med Chem 25: 3964-3970 (2017)
Pukyong National University
Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity.
Bioorg Med Chem 25: 3989-3996 (2017)
Dalian Medical University
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
Bioorg Med Chem Lett 27: 3167-3172 (2017)
Hyogo University Of Health Sciences
Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators.
Eur J Med Chem 137: 63-75 (2017)
Amgen
Synthesis of a new series of aryl/heteroarylpiperazinyl derivatives of 8-acetyl-7-hydroxy-4-methylcoumarin with low nanomolar 5-HT
Eur J Med Chem 137: 108-116 (2017)
Medical University Of Warsaw
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor.
J Med Chem 60: 5673-5698 (2017)
Pfizer
Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.
J Med Chem 60: 5493-5506 (2017)
Heinrich-Heine-Universit£T D£Sseldorf
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists.
Bioorg Med Chem 25: 3631-3637 (2017)
University Of Messina
Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
Bioorg Med Chem 25: 3768-3779 (2017)
Takeda Pharmaceutical
Design, synthesis and SAR of new-di-substituted pyridopyrimidines as ATP-competitive dual PI3K?/mTOR inhibitors.
Bioorg Med Chem Lett 27: 3117-3122 (2017)
Temple University
Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing's Disease.
J Med Chem 60: 5086-5098 (2017)
Saarland University
Serendipitous discovery of light-induced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor.
BMC Biochem 18: 1-15 (2017)
Concordia University Of Wisconsin
Development of WNK signaling inhibitors as a new class of antihypertensive drugs.
Bioorg Med Chem 25: 3845-3852 (2017)
Tokyo Medical And Dental University (Tmdu)
Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes.
J Med Chem 60: 5209-5215 (2017)
Takeda California
Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins.
J Med Chem 60: 5377-5391 (2017)
German University In Cairo
Halogen-substituted catechol bisphosphates are potent and selective inhibitors of the transcription factor STAT5b.
Bioorg Med Chem 25: 3871-3882 (2017)
Leipzig University
Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors.
Bioorg Med Chem Lett 27: 3037-3042 (2017)
Merck
Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents.
Eur J Med Chem 137: 96-107 (2017)
Shenyang Pharmaceutical University
Inhibition Potential of Cycloartane-Type Glycosides from the Roots of Cimicifuga dahurica against Soluble Epoxide Hydrolase.
J Nat Prod 80: 1867-1875 (2017)
Chungnam National University
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.
J Med Chem 60: 4869-4881 (2017)
Novartis Institutes For Biomedical Research
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.
J Med Chem 60: 5146-5161 (2017)
Bayer
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.
J Med Chem 60: 4949-4962 (2017)
University Of Kaiserslautern
Design, synthesis of novel furan appended benzothiazepine derivatives and in vitro biological evaluation as potent VRV-PL-8a and H
Bioorg Med Chem Lett 27: 3048-3054 (2017)
University Of Mysore
Design and synthesis of potent HIV-1 protease inhibitors with (S)-tetrahydrofuran-tertiary amine-acetamide as P2-ligand: Structure-activity studies and biological evaluation.
Eur J Med Chem 137: 30-44 (2017)
Chinese Academy Of Medical Science And Peking Union Medical College
One-pot microwave assisted stereoselective synthesis of novel dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and evaluation of their antimycobacterial activity and inhibition of AChE.
Bioorg Med Chem Lett 27: 3071-3075 (2017)
Madurai Kamaraj University
Sialidase inhibitory activity of diarylnonanoid and neolignan compounds extracted from the seeds of Myristica fragrans.
Bioorg Med Chem Lett 27: 3060-3064 (2017)
Korea Research Institute Of Bioscience And Biotechnology
Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease.
Bioorg Med Chem 25: 3815-3826 (2017)
China Pharmaceutical University
Synthesis and evaluation of novel dual BRD4/HDAC inhibitors.
Bioorg Med Chem 25: 3677-3684 (2017)
The University Of Tokyo
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
J Med Chem 60: 5002-5014 (2017)
Novartis Institutes For Biomedical Research
Subtly Modulating Glycogen Synthase Kinase 3?: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases.
J Med Chem 60: 4983-5001 (2017)
Centro De Investigaciones Biol�Gicas-Csic
Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.
J Med Chem 60: 5228-5234 (2017)
Tokyo University Of Pharmacy And Life Sciences
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1.
Bioorg Med Chem Lett 27: 3190-3195 (2017)
University Of Manchester
Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.
Bioorg Med Chem 25: 3714-3718 (2017)
Istanbul University
Carboxylated aurone derivatives as potent inhibitors of xanthine oxidase.
Bioorg Med Chem 25: 3606-3613 (2017)
National Academy Of Sciences Of Ukraine
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase? (PI3K?) Inhibitor for the Treatment of Immunological Disorders.
J Med Chem 60: 5193-5208 (2017)
Bristol-Myers Squibb
Discovery of Potent, Selective Stem Cell Factor Receptor/Platelet Derived Growth Factor Receptor Alpha (c-KIT/PDGFRa) Dual Inhibitor for the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs).
J Med Chem 60: 5099-5119 (2017)
East China University Of Science And Technology
Bioactive Glycosides from the Twigs of Litsea cubeba.
J Nat Prod 80: 1808-1818 (2017)
Lanzhou University
Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo.
J Med Chem 60: 5162-5192 (2017)
Chinese Academy Of Medical Sciences And Peking Union Medical College
Lodopyridones B and C from a marine sediment-derived bacterium Saccharomonospora sp.
Bioorg Med Chem Lett 27: 3123-3126 (2017)
Ewha Womans University
Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors.
Bioorg Med Chem Lett 27: 3101-3106 (2017)
Bristol-Myers Squibb Research And Development
Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.
Bioorg Med Chem Lett 27: 3201-3204 (2017)
Sichuan University
Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor?/? (PPAR?/?) dual agonists.
Bioorg Med Chem Lett 27: 3131-3134 (2017)
The University Of Tokyo
Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities.
J Med Chem 60: 5029-5044 (2017)
University Of Colorado Boulder
Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures.
J Med Chem 60: 4840-4860 (2017)
Eth Zurich
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.
J Med Chem 60: 7941-7957 (2017)
University Of Porto
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11?-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.
J Med Chem 60: 4932-4948 (2017)
Bristol-Myers Squibb
Novel propanamides as fatty acid amide hydrolase inhibitors.
Eur J Med Chem 136: 523-542 (2017)
University Of Cagliari
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.
J Med Chem 60: 4963-4982 (2017)
H�Pital Saint-Fran�Ois D'Assise
BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.
J Med Chem 60: 4805-4817 (2017)
University Of Minnesota
2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase.
Bioorg Med Chem 25: 3658-3670 (2017)
Takeda Pharmaceutical
Design, synthesis and biological evaluation of 4-piperazinyl-containing Chidamide derivatives as HDACs inhibitors.
Bioorg Med Chem Lett 27: 3162-3166 (2017)
Shanghai Institute Of Pharmaceutical Industry
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.
J Med Chem 60: 5120-5145 (2017)
University Of Pennsylvania
Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation.
J Med Chem 60: 5072-5085 (2017)
Vanderbilt University Institute Of Imaging Science
The impact of the halogen bonding on D
Bioorg Med Chem 25: 3638-3648 (2017)
Jagiellonian University Medical College
Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors.
Bioorg Med Chem 25: 3614-3622 (2017)
Sookmyung Women'S University
Discovery of a potent dual ALK and EGFR T790M inhibitor.
Eur J Med Chem 136: 497-510 (2017)
Harvard Medical School
Nanomolar anti-sickling compounds identified by ligand-based pharmacophore approach.
Eur J Med Chem 136: 487-496 (2017)
Universidade Estadual De Feira De Santana
Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11? hydroxysteroid dehydrogenase type 1 inhibitor.
Bioorg Med Chem 25: 3649-3657 (2017)
Vitae Pharmaceuticals
Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
Bioorg Med Chem 25: 3780-3791 (2017)
Fudan University
Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance.
Eur J Med Chem 142: 32-47 (2017)
R. C. Patel Institute Of Pharmaceutical Education And Research
Synthesis and biological evaluation of kresoxim-methyl analogues as novel inhibitors of hypoxia-inducible factor (HIF)-1 accumulation in cancer cells.
Bioorg Med Chem Lett 27: 3026-3029 (2017)
Yeungnam University
Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
Bioorg Med Chem Lett 27: 3014-3018 (2017)
Recep Tayyip Erdogan University
Discovery of a novel aminopyrazine series as selective PI3K? inhibitors.
Bioorg Med Chem Lett 27: 3030-3035 (2017)
Astrazeneca
The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
Eur J Med Chem 136: 457-467 (2017)
Qilu University Of Technology
Structure-based rational design of self-inhibitory peptides to disrupt the intermolecular interaction between the troponin subunits C and I in neuropathic pain.
Bioorg Chem 73: 10-15 (2017)
The Affiliated Hospital Of Qingdao University
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP
ACS Med Chem Lett 8: 582-586 (2017)
Novartis Institutes For Biomedical Research
Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes.
ACS Med Chem Lett 8: 560-565 (2017)
Janssen Research And Development
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4.
ACS Med Chem Lett 8: 549-554 (2017)
Glaxosmithkline
2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors.
ACS Med Chem Lett 8: 543-548 (2017)
Chinese Academy Of Sciences
Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis.
ACS Med Chem Lett 8: 533-537 (2017)
Peking Union Medical College And Chinese Academy Of Medical Sciences
Design and Synthesis of Mercaptoacetamides as Potent, Selective, and Brain Permeable Histone Deacetylase 6 Inhibitors.
ACS Med Chem Lett 8: 510-515 (2017)
University Of Illinois At Chicago
Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket.
ACS Med Chem Lett 8: 504-509 (2017)
The University Of Tokyo
Identification of New FLT3 Inhibitors That Potently Inhibit AML Cell Lines via an Azo Click-It/Staple-It Approach.
ACS Med Chem Lett 8: 492-497 (2017)
Purdue University
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology.
ACS Med Chem Lett 8: 486-491 (2017)
Incyte
Similarity- and Substructure-Based Development ofß
ACS Med Chem Lett 8: 481-485 (2017)
Philipps University Marburg
Modulation of the Inhibitors of Apoptosis Proteins (IAPs) Activities for Cancer Treatment.
ACS Med Chem Lett 8: 471-473 (2017)
Therachem Research Medilab (India)
Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
Bioorg Med Chem 25: 3567-3573 (2017)
Universit£
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
Bioorg Med Chem 25: 3706-3713 (2017)
Peking University
Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities.
Bioorg Med Chem Lett 27: 2742-2745 (2017)
Kitasato University
Challenges in the development of an M
Bioorg Med Chem Lett 27: 2990-2995 (2017)
Vanderbilt University School Of Medicine
Hetarylcoumarins: Synthesis and biological evaluation as potent a-glucosidase inhibitors.
Bioorg Chem 73: 1-9 (2017)
Kinnaird College For Women
2-Oxo-3, 4-dihydropyrimido[4, 5-d]pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitors.
Eur J Med Chem 135: 531-543 (2017)
Guangzhou Institutes Of Biomedicine And Health
Design and Synthesis of Soluble and Cell-Permeable PI3K? Inhibitors for Long-Acting Inhaled Administration.
J Med Chem 60: 5057-5071 (2017)
Astrazeneca
Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles.
J Med Chem 60: 4904-4922 (2017)
Clemson University
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.
Bioorg Med Chem Lett 27: 2974-2981 (2017)
Genentech
Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators.
Bioorg Med Chem Lett 27: 2678-2682 (2017)
Takeda California
Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Bioorg Med Chem Lett 27: 2645-2649 (2017)
Health Sciences University Of Hokkaido
Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-?-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
Bioorg Med Chem Lett 27: 2962-2966 (2017)
University Of Utah
Sulfonamide inhibition profiles of the?-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia.
Bioorg Med Chem 25: 3555-3561 (2017)
Universit£
Potential anti-gout constituents as xanthine oxidase inhibitor from the fruits of Stauntonia brachyanthera.
Bioorg Med Chem 25: 3562-3566 (2017)
Shenyang Pharmaceutical University
Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
Bioorg Med Chem 25: 3547-3554 (2017)
Anadolu University
Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups.
Bioorg Med Chem 25: 2981-2994 (2017)
Shandong University
Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B.
Eur J Med Chem 136: 348-359 (2017)
Chinese Academy Of Sciences
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.
J Med Chem 60: 4279-4292 (2017)
Karolinska Institutet
Phenylbenzenesulfonates and -sulfonamides as 17?-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis.
Bioorg Med Chem Lett 27: 2982-2985 (2017)
University Of Innsbruck
Recent progress towards clinically relevant ATP-competitive Akt inhibitors.
Bioorg Med Chem Lett 27: 2838-2848 (2017)
Merck
Development of nonsteroidal glucocorticoid receptor modulators based on N-benzyl-N-(4-phenoxyphenyl)benzenesulfonamide scaffold.
Bioorg Med Chem 25: 3461-3470 (2017)
The University Of Tokyo
Dual functional small molecule fluorescent probes for image-guided estrogen receptor-specific targeting coupled potent antiproliferative potency for breast cancer therapy.
Bioorg Med Chem 25: 3531-3539 (2017)
Wuhan University School Of Pharmaceutical Sciences
Synthesis and pharmacological evaluation of neurosteroid photoaffinity ligands.
Eur J Med Chem 136: 334-347 (2017)
University Of Illinois At Chicago
Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists.
Eur J Med Chem 136: 330-333 (2017)
The University Of Sydney
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Eur J Med Chem 136: 315-329 (2017)
National Research Centre
Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors.
Eur J Med Chem 136: 294-304 (2017)
University Of Maribor
Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.
Eur J Med Chem 136: 283-293 (2017)
Takeda Pharmaceutical
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.
J Med Chem 61: 3239-3252 (2018)
Temple University
Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study.
Bioorg Med Chem 25: 3500-3511 (2017)
Shenyang Pharmaceutical University
Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment.
Bioorg Chem 72: 315-322 (2017)
Medical University Of Lodz
Stabilizing HDAC11 with SAHA to assay slow-binding benzamide inhibitors.
Bioorg Med Chem Lett 27: 2943-2945 (2017)
Nankai University
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation.
Bioorg Med Chem Lett 27: 2721-2726 (2017)
Astrazeneca
Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pure? ligands with 2-benzopyran structure.
Bioorg Med Chem 25: 3384-3395 (2017)
Universit£T M£Nster
Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors.
Bioorg Chem 72: 308-314 (2017)
Cairo University
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of?-opioid receptor antagonists.
Bioorg Med Chem Lett 27: 2926-2930 (2017)
Theravance Biopharma Us
Quinazoline based ?
Eur J Med Chem 136: 259-269 (2017)
Alma Mater Studiorum-University Of Bologna
Novel Imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides as antiproliferative trypanosoma cruzi drugs: Computational screening from neural network, synthesis and in vivo biological properties.
Eur J Med Chem 136: 223-234 (2017)
Instituto De Qu£Mica M£Dica
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design.
J Med Chem 60: 5521-5542 (2017)
Pfizer
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.
J Med Chem 60: 4657-4664 (2017)
Novartis Institutes For Biomedical Research
Development of molecular tools based on the dopamine D
Bioorg Med Chem 25: 3491-3499 (2017)
Friedrich-Alexander University
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
Bioorg Med Chem 25: 3471-3482 (2017)
University Of Cambridge
Reevaluation of fenpropimorph as a? receptor ligand: Structure-affinity relationship studies at human?
Bioorg Med Chem Lett 27: 2912-2919 (2017)
Virginia Commonwealth University
Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14.
Bioorg Med Chem Lett 27: 2907-2911 (2017)
Mcdaniel College
Designing multi-targeted agents: An emerging anticancer drug discovery paradigm.
Eur J Med Chem 136: 195-211 (2017)
Hunan University Of Chinese Medicine
Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.
Eur J Med Chem 136: 184-194 (2017)
Birla Institute Of Technology
Tamarixetin 3-O-?-d-Glucopyranoside from Azadirachta indica Leaves: Gastroprotective Role through Inhibition of Matrix Metalloproteinase-9 Activity in Mice.
J Nat Prod 80: 1347-1353 (2017)
National Institute Of Pharmaceutical Education And Research
Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic Acid Arylamides as Inhibitors of the Calcium-Activated Chloride Channel Transmembrane Protein 16A (TMEM16A).
J Med Chem 60: 4626-4635 (2017)
San Francisco State University
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate.
J Med Chem 60: 4559-4572 (2017)
Janssen Research And Development
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP).
J Med Chem 60: 4611-4625 (2017)
Astex Pharmaceuticals
Return of D
J Med Chem 60: 7233-7243 (2017)
University Of Nebraska Medical Center
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for?-Arrestin-Biased D
J Med Chem 60: 4693-4713 (2017)
Friedrich-Alexander University Erlangen-Nuernberg
Atropisomerism and Conformational Equilibria: Impact on PI3K? Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.
J Med Chem 60: 4304-4315 (2017)
Universit£
Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Bioorg Med Chem 25: 3006-3017 (2017)
Nanyang Normal University
N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1?/? inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Bioorg Med Chem Lett 27: 2663-2667 (2017)
Rajiv Gandhi Proudyogiki Vishwavidyalaya
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.
J Med Chem 60: 4386-4402 (2017)
Astrazeneca
Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPAR?-Targeted Antidiabetics.
J Med Chem 60: 4584-4593 (2017)
The Scripps Research Institute
Identification of novel 1,2,3,6-tetrahydropyridyl-substituted benzo[d]thiazoles: Lead generation and optimization toward potent and orally active EP
Bioorg Med Chem 25: 3406-3430 (2017)
Kyorin Pharmaceutical
Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance.
Bioorg Med Chem 25: 3158-3170 (2017)
Ludwig-Maximilians-University Munich
Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.
Eur J Med Chem 136: 63-73 (2017)
China Pharmaceutical University
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
J Med Chem 60: 7213-7232 (2017)
King'S College London
Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping.
J Med Chem 60: 4636-4656 (2017)
Eberhard Karls Universit£T T£Bingen
1,4,5-Trisubstituted Imidazole-Based p53-MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers.
J Med Chem 60: 4234-4244 (2017)
Jagiellonian University
Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy.
J Med Chem 60: 4594-4610 (2017)
Indiana University School Of Medicine
Efficient Inhibition of SmNACE by Coordination Complexes Is Abolished by S. mansoni Sequestration of Metal.
ACS Chem Biol 12: 1787-1795 (2017)
University Of Strasburg
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
J Med Chem 60: 4424-4443 (2017)
Shandong University
Heme Proximal Hydrogen Bonding between His170 and Asp132 Plays an Essential Role in the Heme Degradation Reaction of HutZ from Vibrio cholerae.
Biochemistry 56: 2723-2734 (2017)
Hokkaido University
Conformational control in structure-based drug design.
Bioorg Med Chem Lett 27: 2825-2837 (2017)
Allergan
Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors.
Bioorg Med Chem Lett 27: 2708-2712 (2017)
Martin-Luther-University Halle-Wittenberg
Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles.
Bioorg Med Chem Lett 27: 2803-2806 (2017)
Chinese Academy Of Sciences
Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Eur J Med Chem 136: 36-51 (2017)
Jamia Millia Islamia (Central University)
Methyllysine binding domains: Structural insight and small molecule probe development.
Eur J Med Chem 136: 14-35 (2017)
University Of Connecticut
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Eur J Med Chem 135: 491-516 (2017)
University Of Nis
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
Eur J Med Chem 135: 467-478 (2017)
Universit£
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.
J Med Chem 60: 4714-4733 (2017)
H�Pital Kirchberg
Tolvaptan-Type Vasopressin Receptor Ligands: Important Role of Axial Chirality in the Active Form.
J Med Chem 60: 4503-4509 (2017)
Teikyo University
Pentafluorosulfanyl-Substituted Benzopyran Analogues As New Cyclooxygenase-2 Inhibitors with Excellent Pharmacokinetics and Efficacy in Blocking Inflammation.
J Med Chem 60: 4135-4146 (2017)
Guangzhou Institutes Of Biomedicine And Health
Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2).
J Med Chem 60: 4403-4423 (2017)
Pharmakea Therapeutics
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.
J Med Chem 60: 4882-4892 (2017)
University Of Milano-Bicocca
Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach.
J Med Chem 60: 4358-4368 (2017)
Takeda Pharmaceutical
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2).
J Med Chem 60: 4474-4495 (2017)
University Of Bonn
Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein.
Bioorg Med Chem Lett 27: 2781-2787 (2017)
The University Of Tokyo
Benzoxazolinone aryl sulfonamides as potent, selective Na
Bioorg Med Chem Lett 27: 2683-2688 (2017)
Merck
Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.
Bioorg Med Chem Lett 27: 2788-2792 (2017)
Beijing Institute Of Pharmacology & Toxicology
Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors.
Bioorg Med Chem Lett 27: 2695-2701 (2017)
Merck
Structure-activity relationships of rosiglitazone for peroxisome proliferator-activated receptor gamma transrepression.
Bioorg Med Chem Lett 27: 2776-2780 (2017)
The University Of Tokyo
Synthesis and biological evaluation of chemokine receptor ligands with 2-benzazepine scaffold.
Eur J Med Chem 135: 401-413 (2017)
Universit£T M£Nster
Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells.
J Med Chem 60: 4665-4679 (2017)
Cnrs-Pierre Fabre Usr3388
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor.
J Med Chem 60: 3887-3901 (2017)
University Of Michigan
Design and optimization of purine derivatives as in vivo active PDE10A inhibitors.
Bioorg Med Chem 25: 3315-3329 (2017)
Nanchang University
Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-?-benzyl ester derivatives as potent topoisomerase II? inhibitors.
Bioorg Med Chem 25: 3116-3126 (2017)
Hebei University
Design, synthesis and evaluation of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acid derivatives as ET
Bioorg Med Chem Lett 27: 2281-2285 (2017)
St. John'S University
Iodine catalyzed three component synthesis of 1-((2-hydroxy naphthalen-1-yl)(phenyl)(methyl))pyrrolidin-2-one derivatives: Rationale as potent PI3K inhibitors and anticancer agents.
Bioorg Med Chem Lett 27: 2510-2514 (2017)
Vit University
The identification of novel acid isostere based inhibitors of the VPS10P family sorting receptor Sortilin.
Bioorg Med Chem Lett 27: 2629-2633 (2017)
Aarhus University
Neutral macrocyclic factor VIIa inhibitors.
Bioorg Med Chem Lett 27: 2650-2654 (2017)
Bristol-Myers Squibb Research And Development
Design, synthesis and biological activity of 3-oxoamino-benzenesulfonamides as selective and reversible LSD1 inhibitors.
Bioorg Chem 72: 182-189 (2017)
China Pharmaceutical University
Synthesis and biological evaluation of benzimidazole derivatives as the G9a Histone Methyltransferase inhibitors that induce autophagy and apoptosis of breast cancer cells.
Bioorg Chem 72: 168-181 (2017)
Shenyang Pharmaceutical University
The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3? inhibitors for the treatment of ovarian cancer.
Eur J Med Chem 135: 370-381 (2017)
Fudan University
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis.
J Med Chem 60: 4212-4233 (2017)
University Of Auckland
Neuroprotective and Antineuroinflammatory Effects of Hydroxyl-Functionalized Stilbenes and 2-Arylbenzo[b]furans.
J Med Chem 60: 4062-4073 (2017)
National Yang-Ming University
Synthesis of selective 11?-HSD1 inhibitors based on dammarane scaffold.
Eur J Med Chem 135: 324-338 (2017)
Chinese Academy Of Sciences
Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem 135: 307-323 (2017)
Sichuan University
Inhibitors of cytochrome P450 (CYP) 1B1.
Eur J Med Chem 135: 296-306 (2017)
Universit£
Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.
Bioorg Med Chem Lett 27: 2757-2761 (2017)
Takeda Pharmaceutical
Antioxidant and anticholinesterase potential of diterpenoid alkaloids from Aconitum heterophyllum.
Bioorg Med Chem 25: 3368-3376 (2017)
University Of Malakand
The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
Eur J Med Chem 135: 196-203 (2017)
North-West University
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate.
Bioorg Med Chem 25: 3330-3349 (2017)
Takeda Pharmaceutical
Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin.
Bioorg Med Chem 25: 2946-2955 (2017)
Sun Yat-Sen University
Structure-related protein tyrosine phosphatase 1B inhibition by naringenin derivatives.
Bioorg Med Chem Lett 27: 2274-2280 (2017)
Chonbuk National University
Synthesis and mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents.
Eur J Med Chem 135: 213-229 (2017)
Universidade Federal Fluminense
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.
Eur J Med Chem 135: 174-195 (2017)
Ghent University
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides.
J Med Chem 60: 4316-4326 (2017)
Universit£
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa
J Med Chem 60: 4342-4357 (2017)
University Of Minnesota
Manzamine Alkaloids from an Acanthostrongylophora sp. Sponge.
J Nat Prod 80: 1575-1583 (2017)
Seoul National University
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.
J Med Chem 60: 4293-4303 (2017)
Sanofi-Aventis Deutschland
Discovery of a Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor (HSK0935) for the Treatment of Type 2 Diabetes.
J Med Chem 60: 4173-4184 (2017)
Haisco Pharmaceuticals Group
Exploring the Role of N
J Med Chem 60: 4327-4341 (2017)
University Of Camerino
Metallo-?-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
Eur J Med Chem 135: 159-173 (2017)
Uit The Arctic University Of Norway
Neomacrophorin X, a [4.4.3]Propellane-Type Meroterpenoid from Trichoderma sp. 1212-03.
J Nat Prod 80: 1484-1492 (2017)
Hirosaki University
Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis.
J Med Chem 60: 3672-3683 (2017)
Novartis Institutes For Biomedical Research
Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer Treatment.
J Med Chem 60: 3626-3635 (2017)
Regina Elena National Cancer Institute
Tricyclic Polyprenylated Acylphloroglucinols from St John's Wort, Hypericum perforatum.
J Nat Prod 80: 1493-1504 (2017)
Chinese Academy Of Sciences
Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability.
J Med Chem 60: 4458-4473 (2017)
Genentech
Synthesis of benzoxazole derivatives as interleukin-6 antagonists.
Bioorg Med Chem 25: 3127-3134 (2017)
Ewha Womans University
Optimization of M
Bioorg Med Chem Lett 27: 2296-2301 (2017)
Vanderbilt University Medical Center
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.
Bioorg Med Chem Lett 27: 2313-2318 (2017)
Ranbaxy Laboratories
Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.
Eur J Med Chem 135: 142-158 (2017)
Palack£
The computer-aided discovery of novel family of the 5-HT
Eur J Med Chem 135: 117-124 (2017)
Jagiellonian University
Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.
Biochemistry 56: 2506-2517 (2017)
University Of Washington
Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy.
J Med Chem 60: 4444-4457 (2017)
F. Hoffmann-La Roche
Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay.
ACS Chem Biol 12: 1760-1768 (2017)
Bc Cancer Agency
Identification of low micromolar dual inhibitors for aldose reductase (ALR2) and poly (ADP-ribose) polymerase (PARP-1) using structure based design approach.
Bioorg Med Chem Lett 27: 2324-2330 (2017)
Punjabi University
Potent and selective oxytocin receptor agonists without disulfide bridges.
Bioorg Med Chem Lett 27: 2331-2335 (2017)
Takeda Pharmaceutical
Small molecules inhibit STAT3 activation, autophagy, and cancer cell anchorage-independent growth.
Bioorg Med Chem 25: 2995-3005 (2017)
Indiana University School Of Medicine
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism.
Eur J Med Chem 134: 334-347 (2017)
Csir-Indian Institute Of Chemical Biology
Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening.
J Med Chem 60: 4093-4098 (2017)
University Of Dundee
Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule Libraries.
ACS Med Chem Lett 8: 461-465 (2017)
Abbvie
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.
ACS Med Chem Lett 8: 455-460 (2017)
The University Of Texas At Austin
Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge.
ACS Med Chem Lett 8: 449-454 (2017)
Universit£
Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit
ACS Med Chem Lett 8: 438-442 (2017)
Harvard University
Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX.
ACS Med Chem Lett 8: 423-427 (2017)
Pharmakea
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.
ACS Med Chem Lett 8: 413-417 (2017)
Kezar Life Sciences
Discovery of Highly Potent 2-Sulfonyl-Pyrimidinyl Derivatives for Apoptosis Inhibition and Ischemia Treatment.
ACS Med Chem Lett 8: 407-412 (2017)
Peking University
Discovery of [1,2,3]Triazolo[4,5-
ACS Med Chem Lett 8: 384-389 (2017)
Key Laboratory Of Technology Of Drug Preparation (Zhengzhou University)
Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.
Bioorg Med Chem 25: 3223-3234 (2017)
University Of Montana
4-Connected azabicyclo[5.3.0]decane Smac mimetics-Zn
Bioorg Med Chem Lett 27: 2336-2344 (2017)
Istituto Di Scienze E Tecnologie Molecolari (Istm)
N-Aryl-N'-ethyleneaminothioureas effectively inhibit acetylcholinesterase 1 from disease-transmitting mosquitoes.
Eur J Med Chem 134: 415-427 (2017)
Ume£
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.
Eur J Med Chem 134: 392-405 (2017)
National Research Centre
Discovery and optimization of selective FGFR4 inhibitors via scaffold hopping.
Bioorg Med Chem Lett 27: 2420-2423 (2017)
Wuxi Apptec (Shanghai)
Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists.
Bioorg Med Chem 25: 3098-3115 (2017)
Takeda Pharmaceutical
Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia.
Eur J Med Chem 135: 60-69 (2017)
Dalian Medical University
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores.
Bioorg Med Chem Lett 27: 2559-2566 (2017)
Merck
First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
Eur J Med Chem 135: 49-59 (2017)
Instituto De Qu£Mica M£Dica (Iqm-Csic)
Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Eur J Med Chem 135: 34-48 (2017)
Wuhan University Of Technology
Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors.
Eur J Med Chem 134: 366-378 (2017)
Padmashri Vikhe Patil College Of Arts
Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
Eur J Med Chem 134: 357-365 (2017)
Ain Shams University
Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells.
Eur J Med Chem 134: 316-333 (2017)
Sapienza University Of Rome
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.
J Med Chem 60: 4369-4385 (2017)
Bristol-Myers Squibb Research And Development
Structure of a Myeloid cell leukemia-1 (Mcl-1) inhibitor bound to drug site 3 of Human Serum Albumin.
Bioorg Med Chem 25: 3087-3092 (2017)
Vanderbilt University
Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitors.
Bioorg Med Chem 25: 3148-3157 (2017)
Jiangxi Science & Technology Normal University
Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1'-P2' ligands.
Bioorg Med Chem Lett 27: 2432-2438 (2017)
Purdue University
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
Bioorg Med Chem Lett 27: 2377-2383 (2017)
Suez Canal University
Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotype.
Bioorg Med Chem Lett 27: 2479-2483 (2017)
Vanderbilt University School Of Medicine
Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
Eur J Med Chem 134: 304-315 (2017)
King Saud University
Design and synthesis of neolamellarin a derivatives targeting heat shock protein 90.
Eur J Med Chem 135: 24-33 (2017)
Ocean University Of China
Design, synthesis, SAR discussion, in vitro and in vivo evaluation of novel selective EGFR modulator to inhibit L858R/T790M double mutants.
Eur J Med Chem 135: 12-23 (2017)
Nanjing Normal University
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ER? and ER? Activity.
J Med Chem 61: 514-534 (2018)
Trinity College
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.
J Med Chem 61: 535-542 (2017)
Celgene
?-Glucosidase Inhibitors from Salvia circinata.
J Nat Prod 80: 1584-1593 (2017)
Universidad Nacional Aut£Noma De M£Xico
Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.
J Med Chem 60: 3958-3978 (2017)
Northwestern University
Synthetic Approaches to the New Drugs Approved During 2015.
J Med Chem 60: 6480-6515 (2017)
Pfizer
Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
Eur J Med Chem 134: 281-292 (2017)
Tsinghua University
Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).
J Med Chem 60: 3275-3288 (2017)
Purdue University
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus.
J Med Chem 60: 3727-3738 (2017)
Universitat De Barcelona
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.
Bioorg Med Chem Lett 27: 2384-2388 (2017)
Merck Research Laboratories
Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
Bioorg Med Chem 25: 3171-3181 (2017)
California State University
N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII.
Bioorg Med Chem 25: 3583-3589 (2017)
Latvian Institute Of Organic Synthesis
Synthesis and biological evaluation of largazole zinc-binding group analogs.
Bioorg Med Chem 25: 3077-3086 (2017)
Duke University
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.
Eur J Med Chem 134: 230-241 (2017)
Xihua University
Design and synthesis of novel xanthine derivatives as potent and selective A
Eur J Med Chem 134: 218-229 (2017)
Advinus Therapeutics
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study.
Eur J Med Chem 134: 185-206 (2017)
Shandong University
Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance.
J Med Chem 60: 4185-4211 (2017)
Universities Of Lille
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fib
J Med Chem 60: 3580-3590 (2017)
Galapagos
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.
Eur J Med Chem 134: 159-184 (2017)
Punjabi University
A calcineurin antifungal strategy with analogs of FK506.
Bioorg Med Chem Lett 27: 2465-2471 (2017)
Amplyx Pharmaceuticals
Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors.
Bioorg Med Chem 25: 3195-3205 (2017)
Hangzhou Xixi Hospital
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization.
Eur J Med Chem 134: 147-158 (2017)
Shanghai Pharmaceuticals Holding
New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
Bioorg Chem 72: 123-129 (2017)
Beni-Suef University
Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors
Bioorg Chem 72: 116-122 (2017)
China Pharmaceutical University
Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain.
Bioorg Med Chem Lett 27: 2472-2478 (2017)
University Of Z£Rich
Design, Synthesis, and Biological Evaluation of Dimorpholine Substituted Thienopyrimidines as Potential Class I PI3K/mTOR Dual Inhibitors.
J Med Chem 60: 4023-4035 (2017)
West China Hospital Of Sichuan University
Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methods.
Bioorg Med Chem Lett 27: 2520-2527 (2017)
Charles River Discovery Research Services
Pharmacological evaluation of a novel series of urea, thiourea and guanidine derivatives as P2X
Bioorg Med Chem Lett 27: 2439-2442 (2017)
The University Of Sydney
Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.
Bioorg Med Chem Lett 27: 2622-2628 (2017)
Mochida Pharmaceutical
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective.
Bioorg Med Chem Lett 27: 2239-2258 (2017)
Intellisyn Pharma
First insight into structure-activity relationships of selective meprin? inhibitors.
Bioorg Med Chem Lett 27: 2428-2431 (2017)
Fraunhofer Institute For Cell Therapy And Immunology Izi
Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus.
Bioorg Med Chem Lett 27: 2617-2621 (2017)
Rigel Pharmaceuticals
Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist.
Bioorg Med Chem Lett 27: 2515-2519 (2017)
Jiangxi University Of Traditional Chinese Medicine
Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure-activity relationship study of 4-epi-jaspine B.
Bioorg Med Chem 25: 3046-3052 (2017)
Kyoto University
An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors.
Eur J Med Chem 132: 322-332 (2017)
Universidade Estadual De Feira De Santana
Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
J Med Chem 60: 3933-3957 (2017)
University Of Virginia
Polyketides and Anthranilic Acid Possessing 6-Deoxy-?-l-talopyranose from a Streptomyces Species.
J Nat Prod 80: 1378-1386 (2017)
Korea Research Institute Of Bioscience And Biotechnology
First Dual Inhibitors of Steroid Sulfatase (STS) and 17?-Hydroxysteroid Dehydrogenase Type 1 (17?-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent Diseases.
J Med Chem 60: 4086-4092 (2017)
Saarland University
Diindolylmethane Derivatives: Potent Agonists of the Immunostimulatory Orphan G Protein-Coupled Receptor GPR84.
J Med Chem 60: 3636-3655 (2017)
University Of Bonn
Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties.
J Med Chem 60: 3472-3483 (2017)
Dart Neuroscience
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.
J Med Chem 60: 3776-3794 (2017)
Actelion Pharmaceuticals
Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents.
J Med Chem 60: 3755-3775 (2017)
Actelion Pharmaceuticals
Phylogenomic Analysis of the Microviridin Biosynthetic Pathway Coupled with Targeted Chemo-Enzymatic Synthesis Yields Potent Protease Inhibitors.
ACS Chem Biol 12: 1538-1546 (2017)
University Of Helsinki
Stereospecific cholinesterase inhibition by O,S-diethylphenylphosphonothioate.
Bioorg Med Chem 25: 3053-3058 (2017)
University Of Missouri St. Louis
Structure, synthesis and biological properties of the pentacyclic guanidinium alkaloids.
Bioorg Med Chem 25: 2817-2824 (2017)
Nc State University
Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors.
Bioorg Med Chem Lett 27: 2544-2548 (2017)
University Of Science And Technology Of China
Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.
Bioorg Med Chem Lett 27: 2536-2543 (2017)
Spanish National Cancer Research Centre (Cnio)
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.
J Med Chem 60: 4002-4022 (2017)
Bayer
Efficient synthesis of a multi-substituted diphenylmethane skeleton as a steroid mimetic.
Bioorg Med Chem Lett 27: 2590-2593 (2017)
National Institute Of Health Sciences
Cytochrome P450 binding studies of novel tacrine derivatives: Predicting the risk of hepatotoxicity.
Bioorg Med Chem Lett 27: 2443-2449 (2017)
University Of Waterloo
Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E
Bioorg Med Chem Lett 27: 2594-2601 (2017)
Glenmark Pharmaceuticals
Practical application of 3-substituted-2,6-difluoropyridines in drug discovery: Facile synthesis of novel protein kinase C theta inhibitors.
Bioorg Med Chem Lett 27: 2497-2501 (2017)
Takeda Pharmaceutical
Investigation of the inhibitory mechanism of apomorphine against MDM2-p53 interaction.
Bioorg Med Chem Lett 27: 2571-2574 (2017)
Kyoto University
Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
Bioorg Med Chem 25: 3093-3097 (2017)
Adiyaman University
Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.
Eur J Med Chem 134: 86-96 (2017)
Institute Of Genetics And Molecular And Cellular Biology (Igbmc)
Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists.
Eur J Med Chem 134: 62-71 (2017)
University Of Texas Medical Branch
Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair.
J Med Chem 60: 3979-4001 (2017)
Ut Southwestern Medical Center
Sesquiterpene Quinones/Hydroquinones from the Marine Sponge Spongia pertusa Esper.
J Nat Prod 80: 1436-1445 (2017)
Shanghai Jiao Tong University
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis.
J Med Chem 60: 3383-3404 (2017)
Glaxosmithkline
Synthesis and biological evaluation of morpholine-substituted diphenylpyrimidine derivatives (Mor-DPPYs) as potent EGFR T790M inhibitors with improved activity toward the gefitinib-resistant non-small cell lung cancers (NSCLC).
Eur J Med Chem 133: 329-339 (2017)
Dalian Medical University
Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors.
Eur J Med Chem 134: 24-33 (2017)
Chinese Academy Of Sciences
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo.
Eur J Med Chem 134: 13-23 (2017)
Taipei Medical University (Tmu)
Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels.
J Med Chem 60: 4680-4692 (2017)
Key Laboratory Of Combinatorial Biosynthesis And Drug Discovery (Moe) And Hubei Provinc
N-(Aroyl)-N-(arylmethyloxy)-?-alanines: Selective inhibitors of aldose reductase.
Bioorg Med Chem 25: 3068-3076 (2017)
Universit£
Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential.
Bioorg Med Chem 25: 3018-3033 (2017)
Takeda Pharmaceutical
Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKC?, PKC?, and RasGRP.
Bioorg Med Chem 25: 2971-2980 (2017)
National Institute Of Industrial Technology
Novel 5-HT
Bioorg Med Chem 25: 2789-2799 (2017)
Jagiellonian University Medical College
Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
Eur J Med Chem 134: 1-12 (2017)
Beijing University Of Chemical Technology
Carbohydrazones as new class of carbonic anhydrase inhibitors: Synthesis, kinetics, and ligand docking studies.
Bioorg Chem 72: 89-101 (2017)
University Of Karachi
New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
Bioorg Chem 72: 102-115 (2017)
Alexandria University
Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).
Bioorg Med Chem Lett 27: 2099-2101 (2017)
University Of East Anglia
Discovery of 4-amino-3-arylsulfoquinolines, a novel non-acetylenic chemotype of metabotropic glutamate 5 (mGlu
Eur J Med Chem 133: 240-254 (2017)
Gedeon Richter
A bromopyrrole-containing diterpene alkaloid from the Okinawan marine sponge Agelas nakamurai activates the insulin pathway in Huh-7 human hepatoma cells by inhibiting protein tyrosine phosphatase 1B.
Bioorg Med Chem Lett 27: 2207-2209 (2017)
Tohoku Medical And Pharmaceutical University
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na
Bioorg Med Chem Lett 27: 2087-2093 (2017)
Department Of Discovery Chemistry Merck
Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist.
Bioorg Med Chem 25: 5142-5147 (2017)
Universita' Degli Studi Di Milano
Mycobacterium tuberculosis lysine-?-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors.
Bioorg Med Chem 25: 2761-2771 (2017)
Birla Institute Of Technology & Science-Pilani
Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
Bioorg Med Chem 25: 2782-2788 (2017)
Universit£
Design, synthesis, and biological activity of novel tetrahydropyrazolopyridone derivatives as FXa inhibitors with potent anticoagulant activity.
Bioorg Med Chem 25: 2800-2810 (2017)
Shenyang Pharmaceutical University
Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Eur J Med Chem 133: 184-196 (2017)
Shanghai University Of Traditional Chinese Medicine
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M
J Med Chem 60: 3314-3334 (2017)
University Of Regensburg
Interaction of Azole-Based Environmental Pollutants with the Coelomic Hemoglobin from Amphitrite ornata: A Molecular Basis for Toxicity.
Biochemistry 56: 2294-2303 (2017)
North Carolina State University
C-2 (E)-4-(Styryl)aniline substituted diphenylpyrimidine derivatives (Sty-DPPYs) as specific kinase inhibitors targeting clinical resistance related EGFR
Bioorg Med Chem 25: 2724-2729 (2017)
Dalian Medical University
Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitors.
Bioorg Med Chem Lett 27: 2144-2147 (2017)
Hokkaido University
Novel 2,4-diaminopyrimidines bearing fused tricyclic ring moiety for anaplastic lymphoma kinase (ALK) inhibitor.
Bioorg Med Chem Lett 27: 2185-2191 (2017)
University Of Science & Technology
The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.
Bioorg Med Chem Lett 27: 2210-2215 (2017)
Wuxi Apptec (Shanghai)
Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer.
Bioorg Med Chem Lett 27: 2216-2220 (2017)
Drexel University College Of Medicine
Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
Eur J Med Chem 133: 97-106 (2017)
Jiangxi Science And Technology Normal University
Synthesis and preliminary biological assay of uridine glycoconjugate derivatives containing amide and/or 1,2,3-triazole linkers.
Bioorg Chem 72: 80-88 (2017)
Silesian University Of Technology
Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
J Med Chem 60: 6461-6479 (2017)
Tsinghua University
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).
J Med Chem 61: 482-491 (2018)
University Of Freiburg
Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors.
Bioorg Med Chem Lett 27: 2153-2160 (2017)
Integral Biosciences
Original endomorphin-1 analogues exhibit good analgesic effects with minimal implications for human sperm motility.
Bioorg Med Chem Lett 27: 2119-2123 (2017)
The Reproductive Medicine Special Hospital Of The First Hospital Of Lanzhou University
Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point.
J Med Chem 60: 3438-3450 (2017)
Astrazeneca
Origins of PDZ Binding Specificity. A Computational and Experimental Study Using NHERF1 and the Parathyroid Hormone Receptor.
Biochemistry 56: 2584-2593 (2017)
The University Of Queensland
Multimodal Recognition of Diverse Peptides by the C-Terminal SH2 Domain of Phospholipase C-¿1 Protein.
Biochemistry 56: 2225-2237 (2017)
University Of Colorado Boulder
Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.
J Med Chem 60: 3866-3878 (2017)
The University Of Kansas
Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein Bromodomain.
J Med Chem 60: 5349-5363 (2017)
Pfizer
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy.
J Med Chem 60: 3187-3197 (2017)
Astrazeneca
Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H
Bioorg Med Chem 25: 2701-2712 (2017)
Jagiellonian University Medical College
Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus.
Bioorg Med Chem Lett 27: 2201-2206 (2017)
Sygnature Discovery
Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors.
Bioorg Med Chem Lett 27: 2166-2170 (2017)
Shanghai Jiao Tong University
Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors.
Eur J Med Chem 133: 11-23 (2017)
Shandong University
Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives.
Bioorg Chem 72: 74-79 (2017)
Birla Institute Of Technology
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Eur J Med Chem 132: 294-309 (2017)
China Pharmaceutical University
Enantiospecific Recognition at the A
J Med Chem 60: 3372-3382 (2017)
Uppsala University
Anisucoumaramide, a Bioactive Coumarin from Clausena anisum-olens.
J Nat Prod 80: 798-804 (2017)
Yunnan University
Exploring Derivatives of Quinazoline Alkaloid l-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors.
J Med Chem 60: 3484-3497 (2017)
Csir-Indian Institute Of Integrative Medicine
Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
J Med Chem 60: 3303-3313 (2017)
University Of Montpellier
Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist.
J Med Chem 60: 3405-3421 (2017)
Corcept Therapeutics
Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors.
J Med Chem 60: 3828-3850 (2017)
Abbvie
Design and synthesis of quinazolinones as EGFR inhibitors to overcome EGFR resistance obstacle.
Bioorg Med Chem 25: 2713-2723 (2017)
R. C. Patel Institute Of Pharmaceutical Education And Research
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.
Bioorg Med Chem Lett 27: 1897-1901 (2017)
Takeda Pharmaceutical
Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors.
Bioorg Med Chem 25: 2593-2600 (2017)
Nanjing University
4-Anilino-pyrimidine, novel aldosterone synthase (CYP11B2) inhibitors bearing pyrimidine structures.
Bioorg Med Chem Lett 27: 1902-1906 (2017)
Daiichi Sankyo
Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors.
Bioorg Med Chem Lett 27: 1955-1961 (2017)
Takeda California
Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors.
Bioorg Med Chem 25: 5077-5083 (2017)
University Of Florence
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.
J Med Chem 60: 3335-3351 (2017)
Takeda Pharmaceutical
Discovery of Novel Indazole Derivatives as Orally Available?
J Med Chem 60: 3252-3265 (2017)
Asahi Kasei Pharma
Design, Synthesis, and Experimental Validation of Peptide Ligands Targeting Mycobacterium tuberculosis s Factors.
Biochemistry 56: 2209-2218 (2017)
Indian Institute Of Science
Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth.
Bioorg Med Chem 25: 2609-2616 (2017)
The University Of Texas At Austin
New potent and selective?v?
Bioorg Med Chem Lett 27: 1911-1913 (2017)
Jiangnan University
Synthesis and evaluation of sulfonamide derivatives as potent Human Uric Acid Transporter 1 (hURAT1) inhibitors.
Bioorg Med Chem Lett 27: 1919-1922 (2017)
Chinese Academy Of Sciences
Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors.
Eur J Med Chem 132: 157-172 (2017)
Fudan University
Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays.
Bioorg Med Chem Lett 27: 2003-2009 (2017)
Nanchang University
Discovery of a series of 8-(1-phenylpyrrolidin-2-yl)-6-carboxamide-2-morpholino-4H-chromen-4-one as PI3K?/? inhibitors for the treatment of PTEN-deficient tumours.
Bioorg Med Chem Lett 27: 1949-1954 (2017)
Astrazeneca
Discovery of small molecule inhibitors for the snake venom metalloprotease BaP1 using in silico and in vitro tests.
Bioorg Med Chem Lett 27: 2018-2022 (2017)
Unicamp
Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
Bioorg Med Chem 25: 2569-2576 (2017)
Universit£
Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?
Bioorg Med Chem 25: 5107-5113 (2017)
Helmholtz-Zentrum Dresden-Rossendorf
Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of a-glucosidase.
Bioorg Chem 72: 11-20 (2017)
Csir-Indian Institute Of Chemical Biology
Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng.
J Nat Prod 80: 899-908 (2017)
Chinese Academy Of Sciences
Asymmetric Anchoring Is Required for Efficient O-Loop Opening and Closing in Cytosolic Phosphoenolpyruvate Carboxykinase.
Biochemistry 56: 2106-2115 (2017)
University Of Waterloo
Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate.
Biochemistry 56: 2051-2060 (2017)
University Of Missouri
Lithocholic Acid Hydroxyamide Destabilizes Cyclin D1 and Induces G0/G1 Arrest by Inhibiting Deubiquitinase USP2a.
Cell Chem Biol 24: 458-470 (2017)
Jagiellonian University
Discovery and structure-activity relationship studies of N-substituted indole derivatives as novel Mcl-1 inhibitors.
Bioorg Med Chem Lett 27: 1943-1948 (2017)
Shenyang Pharmaceutical University
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
Bioorg Med Chem 25: 2577-2582 (2017)
University Of Tehran
Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.
Eur J Med Chem 132: 108-134 (2017)
Indo-Soviet Friendship College Of Pharmacy (Isfcp)
Novel pyrazolo[1,5-a]pyridines as orally active EP
Bioorg Med Chem 25: 2635-2642 (2017)
Kyorin Pharmaceutical
Indenocinnoline derivatives as G-quadruplex binders, topoisomerase II? inhibitors and antiproliferative agents.
Bioorg Med Chem 25: 2625-2634 (2017)
National And Kapodistrian University Of Athens
Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
Bioorg Med Chem 25: 2657-2665 (2017)
University Of Oxford
Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.
Bioorg Med Chem 25: 2643-2656 (2017)
University Health Network
Rational design, synthesis, and structure-activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.
Bioorg Med Chem 25: 67-74 (2017)
Advinus Therapeutics
Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
Bioorg Med Chem 25: 166-174 (2017)
Soochow University
Synthesis, activity and docking studies of phenylpyrimidine-carboxamide Sorafenib derivatives.
Bioorg Med Chem 24: 6166-6173 (2016)
Jiangxi Science & Technology Normal University
Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents.
Eur J Med Chem 132: 42-62 (2017)
Mashhad University Of Medical Sciences
Discovery of 2-substituted 1H-benzo[d]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity.
Eur J Med Chem 132: 26-41 (2017)
Chinese Academy Of Medical Sciences & Peking Union Medical College
Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
Bioorg Chem 72: 1-10 (2017)
Warsaw University Of Technology
Embarking on a Chemical Space Odyssey.
J Med Chem 60: 3591-3593 (2017)
University Of Leeds
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.
J Med Chem 60: 3352-3371 (2017)
Roche Innovation Center Shanghai
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor.
J Med Chem 60: 3070-3081 (2017)
University Of Southern California
Discovery of 4-((3'R,4'S,5'R)-6¿-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2¿-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3¿-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Deve
J Med Chem 60: 2819-2839 (2017)
University Of Michigan Comprehensive Cancer Center
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.
J Med Chem 61: 462-481 (2018)
University Of Michigan Comprehensive Cancer Center
BMS-933043, a Selectivea7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.
ACS Med Chem Lett 8: 366-371 (2017)
Bristol-Myers Squibb
Structure-Activity Relationship Study of QL47: A Broad-Spectrum Antiviral Agent.
ACS Med Chem Lett 8: 344-349 (2017)
Dana-Farber Cancer Institute
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.
ACS Med Chem Lett 8: 338-343 (2017)
Novartis Institutes For Biomedical Research
Crystal Structures of ERAP2 Complexed with Inhibitors Reveal Pharmacophore Requirements for Optimizing Inhibitor Potency.
ACS Med Chem Lett 8: 333-337 (2017)
National Center For Scientific Research Demokritos
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
ACS Med Chem Lett 8: 327-332 (2017)
Jinan University
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin.
ACS Med Chem Lett 8: 321-326 (2017)
Global Blood Therapeutics
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.
ACS Med Chem Lett 8: 316-320 (2017)
Takeda Pharmaceutical
Discovery and Assessment of Atropisomers of (±)-Lesinurad.
ACS Med Chem Lett 8: 299-303 (2017)
Wuxi Apptec
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.
ACS Med Chem Lett 8: 293-298 (2017)
Universit£
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.
ACS Med Chem Lett 8: 281-286 (2017)
Wayne State University
Bicyclic Ketone Sulfonamide Compounds.
ACS Med Chem Lett 8: 278-280 (2017)
Temple University
Sodium Channel Blockers.
ACS Med Chem Lett 8: 275-277 (2017)
Temple University
Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1.
Bioorg Med Chem 25: 2617-2624 (2017)
Nagoya City University
Development of N-hydroxycinnamamide-based HDAC inhibitors with improved HDAC inhibitory activity and in vitro antitumor activity.
Bioorg Med Chem 25: 2666-2675 (2017)
Shandong University
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.
Bioorg Med Chem Lett 27: 2023-2028 (2017)
Glaxosmithkline
Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site.
Eur J Med Chem 132: 1-10 (2017)
Shenyang Pharmaceutical University
Development of a Selective Inhibitor of Protein Arginine Deiminase 2.
J Med Chem 60: 3198-3211 (2017)
University Of Massachusetts Medical School
Ligand-Induced Conformational Change of Insulin-Regulated Aminopeptidase: Insights on Catalytic Mechanism and Active Site Plasticity.
J Med Chem 60: 2963-2972 (2017)
National Center For Scientific Research Demokritos
The Berkeleylactones, Antibiotic Macrolides from Fungal Coculture.
J Nat Prod 80: 1150-1160 (2017)
University Of Illinois At Chicago
Design and synthesis of novel 6-aryl substituted 4-anilinequinazoline derivatives as potential PI3K? inhibitors.
Bioorg Med Chem Lett 27: 1972-1977 (2017)
Xi'An Jiaotong University
(-)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects.
Eur J Med Chem 131: 207-221 (2017)
Yachaytech University
Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.
J Med Chem 60: 3052-3069 (2017)
University Of Michigan
Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor.
ACS Chem Biol 12: 1346-1352 (2017)
Merck
Anti-inflammatory Activity of Natural Geranylated Flavonoids: Cyclooxygenase and Lipoxygenase Inhibitory Properties and Proteomic Analysis.
J Nat Prod 80: 999-1006 (2017)
The Czech Academy Of Sciences
High-content screen using zebrafish (Danio rerio) embryos identifies a novel kinase activator and inhibitor.
Bioorg Med Chem Lett 27: 2029-2037 (2017)
West Virginia University
Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-based?
Bioorg Med Chem 25: 2472-2481 (2017)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.
J Med Chem 60: 3109-3123 (2017)
National Institute Of Diabetes And Digestive And Kidney Diseases
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17?-Hydroxysteroid Dehydrogenase Type 2.
J Nat Prod 80: 965-974 (2017)
University Of Basel
Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase.
Bioorg Med Chem Lett 27: 1649-1653 (2017)
Universidad De Chile
Identification and structure activity relationships of quinoline tertiary alcohol modulators of ROR?t.
Bioorg Med Chem Lett 27: 2047-2057 (2017)
Janssen Pharmaceutica
Cyclic mu-opioid receptor ligands containing multiple N-methylated amino acid residues.
Bioorg Med Chem Lett 27: 1644-1648 (2017)
Medical University Of Lodz
Competitive protein tyrosine phosphatase 1B (PTP1B) inhibitors, prenylated caged xanthones from Garcinia hanburyi and their inhibitory mechanism.
Bioorg Med Chem 25: 2498-2506 (2017)
Gyeongsang National University
Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties.
Bioorg Med Chem 25: 2524-2529 (2017)
Prince Sattam Bin Abdulaziz University
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold.
Bioorg Med Chem 25: 2399-2405 (2017)
Medical University Of Lodz
Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor.
Eur J Med Chem 131: 107-125 (2017)
University Of Science And Technology Of China
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
Bioorg Med Chem Lett 27: 1640-1643 (2017)
Wuhan Institute Of Technology
Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.
Bioorg Med Chem 25: 2491-2497 (2017)
Wuhan Institute Of Technology
Design, synthesis and biological evaluation of 7-methylimidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD4 inhibitors.
Bioorg Med Chem 25: 2482-2490 (2017)
China Pharmaceutical University
Modulation of opioid receptor affinity and efficacy via N-substitution of 9?-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.
Bioorg Med Chem 25: 2406-2422 (2017)
National Institute On Drug Abuse And The National Institute On Alcohol Abuse
t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Bioorg Med Chem 25: 2451-2462 (2017)
Seoul National University
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays.
ACS Chem Biol 12: 1390-1396 (2017)
University Of Cambridge
Development of Potent and Selective Antagonists for the UTP-Activated P2Y
J Med Chem 60: 3020-3038 (2017)
University Of Bonn
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis.
J Med Chem 60: 3703-3726 (2017)
University Of Liverpool
Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property.
Bioorg Med Chem 25: 2387-2398 (2017)
China Pharmaceutical University
Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
Bioorg Med Chem 25: 2437-2444 (2017)
University Of Iowa
Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives.
Bioorg Med Chem 25: 2336-2350 (2017)
Takeda Pharmaceutical
Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Bioorg Med Chem 25: 2351-2371 (2017)
University Of Karachi
Evaluation of selenide, diselenide and selenoheterocycle derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors.
Bioorg Med Chem 25: 2518-2523 (2017)
Universit£
Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii.
Bioorg Med Chem Lett 27: 1705-1708 (2017)
University Of Georgia
Structure-based discovery of LpxC inhibitors.
Bioorg Med Chem Lett 27: 1670-1680 (2017)
Cubist Pharmaceuticals
MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Eur J Med Chem 131: 92-106 (2017)
Anadolu University
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
J Med Chem 60: 2930-2943 (2017)
China Pharmaceutical University
Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein-Protein Interaction.
J Med Chem 60: 3511-3517 (2017)
Janssen Research And Development
Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D
J Med Chem 60: 2890-2907 (2017)
National Institute On Drug Abuse-Intramural Research Program
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERa+ Breast Cancer.
J Med Chem 60: 2790-2818 (2017)
Novartis Institutes For Biomedical Research
Biseokeaniamides A, B, and C, Sterol O-Acyltransferase Inhibitors from an Okeania sp. Marine Cyanobacterium.
J Nat Prod 80: 1161-1166 (2017)
Keio University
Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.
Bioorg Med Chem Lett 27: 1709-1713 (2017)
Takeda California
Synthesis and evaluation of a ligand targeting the? and? opioid receptors for drug delivery to lung cancer.
Bioorg Med Chem Lett 27: 2074-2078 (2017)
Purdue University
Synthesis and molecular docking studies of new furochromone derivatives as p38? MAPK inhibitors targeting human breast cancer MCF-7 cells.
Bioorg Med Chem 25: 2423-2436 (2017)
Cairo University
First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-¿B Activity As Novel Anticancer Agents.
J Med Chem 60: 2853-2868 (2017)
Saarland University
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P
J Med Chem 60: 5267-5289 (2017)
Bristol-Myers Squibb
Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders.
Eur J Med Chem 131: 68-80 (2017)
Tripura University
Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.
Eur J Med Chem 131: 29-47 (2017)
University Of Karachi
In silico design of novel probes for the atypical opioid receptor MRGPRX2.
Nat Chem Biol 13: 529-536 (2017)
University Of North Carolina
Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.
J Med Chem 60: 2732-2744 (2017)
University Of Gdansk
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR.
J Med Chem 60: 3002-3019 (2017)
Wuxi Apptec
Price for Opening the Transient Specificity Pocket in Human Aldose Reductase upon Ligand Binding: Structural, Thermodynamic, Kinetic, and Computational Analysis.
ACS Chem Biol 12: 1397-1415 (2017)
Philipps-Universität Marburg
Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors.
J Med Chem 60: 2485-2497 (2017)
Roche Pharmaceutical Research And Early Development (Pred)
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
Eur J Med Chem 131: 14-28 (2017)
Guru Nanak Dev University
Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.
Bioorg Med Chem 25: 5041-5049 (2017)
National Cancer Institute-Frederick
Design, synthesis and structure-activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker.
Bioorg Med Chem 25: 2445-2450 (2017)
China Pharmaceutical University
Evaluation of anti-diabetic effect and gall bladder function with 2-thio-5-thiomethyl substituted imidazoles as TGR5 receptor agonists.
Bioorg Med Chem Lett 27: 1760-1764 (2017)
Janssen Research And Development
Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain.
Bioorg Med Chem 25: 2177-2190 (2017)
Shionogi
Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones.
Bioorg Med Chem 25: 2133-2147 (2017)
Takeda Pharmaceutical
Role of the sugar moiety on the opioid receptor binding and conformation of a series of enkephalin neoglycopeptides.
Bioorg Med Chem 25: 2260-2265 (2017)
Instituto De Qu£Mica Avanzada De Catalu£A (Iqac-Csic)
Investigation on cellular uptake and pharmacodynamics of DOCK2-inhibitory peptides conjugated with cell-penetrating peptides.
Bioorg Med Chem 25: 2148-2155 (2017)
Takeda Pharmaceutical
Biological evaluation of pyridone alkaloids on the endocannabinoid system.
Bioorg Med Chem 25: 6102-6114 (2017)
University Of Bern
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.
Bioorg Med Chem Lett 27: 2063-2068 (2017)
Merck
Synthesis of novel 1,2,4-triazine scaffold as FAK inhibitors with antitumor activity.
Bioorg Med Chem Lett 27: 1727-1730 (2017)
University Of Paris
Novel 2-phenyl-4,5,6,7-tetrahydro[b]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies.
Bioorg Med Chem Lett 27: 1721-1726 (2017)
Institute Of Chemical Technology
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Bioorg Med Chem Lett 27: 2069-2073 (2017)
Merck
Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy.
Eur J Med Chem 131: 1-13 (2017)
Shenyang Pharmaceutical University
Discovery of selective ATP-competitive eIF4A3 inhibitors.
Bioorg Med Chem 25: 2200-2209 (2017)
Takeda Pharmaceutical
Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.
Bioorg Med Chem Lett 27: 1633-1639 (2017)
University Of Texas Medical Branch
Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease.
Eur J Med Chem 130: 440-457 (2017)
Federal University Of Alfenas
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode.
J Med Chem 60: 2944-2962 (2017)
High Magnetic Field Laboratory
Non-kinase targets of protein kinase inhibitors.
Nat Rev Drug Discov 16: 424-440 (2017)
The University Of Sydney
Discovery and pharmacological evaluation of a novel series of adamantyl cyanoguanidines as P2X
Eur J Med Chem 130: 433-439 (2017)
The University Of Sydney
Discovery of novel furanone derivatives as potent Cdc7 kinase inhibitors.
Eur J Med Chem 130: 406-418 (2017)
Carna Biosciences
Design, synthesis, and biological evaluation of novel 4-anilinoquinazoline derivatives bearing amino acid moiety as potential EGFR kinase inhibitors.
Eur J Med Chem 130: 393-405 (2017)
Xuzhou Medical University
Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem 130: 379-392 (2017)
Nanyang Normal University
Green synthesis of novel spiro-indenoquinoxaline derivatives and their cholinesterases inhibition activity.
Bioorg Med Chem 25: 2057-2064 (2017)
Persian Gulf University
Identification of a novel hormone sensitive lipase inhibitor with a reduced potential of reactive metabolites formation.
Bioorg Med Chem 25: 2234-2243 (2017)
Daiichi Sankyo
Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim.
Bioorg Med Chem Lett 27: 1874-1879 (2017)
Chungnam National University
Discovery and evaluation of 1H-pyrrolo[2,3-b]pyridine based selective and reversible small molecule BTK inhibitors for the treatment of rheumatoid arthritis.
Bioorg Med Chem Lett 27: 1867-1873 (2017)
Advinus Therapeutics
Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy.
J Med Chem 60: 2780-2789 (2017)
University Of Aberdeen
Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold.
J Med Chem 60: 2697-2717 (2017)
Shanghai Institute Of Materia Medica
Bortezomib inhibits mammalian carbonic anhydrases.
Bioorg Med Chem 25: 5064-5067 (2017)
Universit£
Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors.
Bioorg Med Chem 25: 2266-2276 (2017)
Chonnam National University
Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2.
Bioorg Med Chem 25: 2277-2284 (2017)
University Of Tartu
Identification of novel TACE inhibitors compatible with topical application.
Bioorg Med Chem Lett 27: 1848-1853 (2017)
Nestl�
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties.
Bioorg Med Chem Lett 27: 1840-1847 (2017)
Gilead Sciences
Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism.
Bioorg Med Chem Lett 27: 1826-1830 (2017)
Hanyang University
Discovery of highly selective and potent monoamine oxidase B inhibitors: Contribution of additional phenyl rings introduced into 2-aryl-1,3,4-oxadiazin-5(6H)-one.
Eur J Med Chem 130: 365-378 (2017)
Seoul National University
Lead Development of Thiazolylsulfonamides with Carbonic Anhydrase Inhibitory Action.
J Med Chem 60: 3154-3164 (2017)
Universit£
Discovery of new Syk inhibitors through structure-based virtual screening.
Bioorg Med Chem Lett 27: 1776-1779 (2017)
Second Military Medical University
Chemical and bioactivity of flavanones obtained from roots of Dalea pazensis Rusby.
Bioorg Med Chem Lett 27: 1789-1794 (2017)
Universidad Nacional De C£Rdoba
Methylpyrrole inhibitors of BET bromodomains.
Bioorg Med Chem Lett 27: 2225-2233 (2017)
Abbvie
Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Bioorg Chem 71: 305-314 (2017)
Sichuan University
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
J Med Chem 60: 3124-3153 (2017)
Lindsey F. Kimball Research Institute
Exploiting sp(2) -Hybridisation in the Development of Potent 1,5-a-l-Arabinanase Inhibitors.
Chembiochem 18: 974-978 (2017)
University Of Western Australia
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
Cell Chem Biol 24: 371-380 (2017)
University Of Oxford
Rapid Discovery of Potent and Selective Glycosidase-Inhibiting De Novo Peptides.
Cell Chem Biol 24: 381-390 (2017)
The University Of Tokyo
Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
Eur J Med Chem 130: 328-335 (2017)
Aristotle University Of Thessaloniki
Quinazoline derivatives as selective CYP1B1 inhibitors.
Eur J Med Chem 130: 320-327 (2017)
Birla Institute Of Technology
Perfluorinated hydroxamic acids are potent and selective inhibitors of HDAC-like enzymes from Pseudomonas aeruginosa.
Bioorg Med Chem Lett 27: 1508-1512 (2017)
University Of Applied Sciences Darmstadt
Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer.
Bioorg Med Chem 25: 2156-2166 (2017)
The Ohio State University
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.
Bioorg Med Chem 25: 2105-2132 (2017)
Washington University
Green synthesis, inhibition studies of yeast a-glucosidase and molecular docking of pyrazolylpyridazine amines.
Bioorg Chem 71: 170-180 (2017)
University Of The Punjab
Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.
Bioorg Med Chem Lett 27: 1602-1607 (2017)
Duquesne University
Design of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA).
J Med Chem 60: 3094-3108 (2017)
Pfizer
Original endomorphin-1 analogues exhibit good analgesic effects.
Bioorg Med Chem Lett 27: 1557-1560 (2017)
The First Hospital Of Lanzhou University
Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects.
Bioorg Med Chem 25: 2210-2217 (2017)
University Of Wollongong
Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
Bioorg Med Chem Lett 27: 1598-1601 (2017)
Universit£
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding.
Bioorg Med Chem Lett 27: 1576-1583 (2017)
Abbvie
Impact of androstane A- and D-ring inversion on 17ß-hydroxysteroid dehydrogenase type 3 inhibitory activity, androgenic effect and metabolic stability.
Bioorg Med Chem 25: 2065-2073 (2017)
Chu De Qu£Bec-Research Center
Discovery of novel BTK inhibitors with carboxylic acids.
Bioorg Med Chem Lett 27: 1471-1477 (2017)
Merck
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment.
J Med Chem 60: 2456-2469 (2017)
University Of Delhi
Spectroscopic and Computational Investigations of Ligand Binding to IspH: Discovery of Non-diphosphate Inhibitors.
Chembiochem 18: 914-920 (2017)
University Of Illinois
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.
J Med Chem 60: 5235-5266 (2017)
Goethe-University Frankfurt
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors.
J Med Chem 60: 3594-3605 (2017)
Merck
Discovery of benzofuran-3(2H)-one derivatives as novel DRAK2 inhibitors that protect islet?-cells from apoptosis.
Eur J Med Chem 130: 195-208 (2017)
East China Normal University
Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure.
J Med Chem 60: 2908-2929 (2017)
Friedrich-Alexander University Erlangen-N£Rnberg
Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
Eur J Med Chem 130: 171-184 (2017)
University Of Ljubljana
Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
Eur J Med Chem 130: 154-170 (2017)
Svkm'S Dr. Bhanuben Nanavati College Of Pharmacy
Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity.
Bioorg Chem 71: 244-256 (2017)
Charles University
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity.
J Med Chem 60: 2983-2992 (2017)
Merck
Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking.
J Med Chem 60: 2718-2731 (2017)
The Ohio State University
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11.
Nat Chem Biol 13: 486-493 (2017)
California Institute Of Technology
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The"Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
J Med Chem 60: 2605-2628 (2017)
Virginia Commonwealth University
Design, synthesis and evaluation of derivatives based on pyrimidine scaffold as potent Pan-Raf inhibitors to overcome resistance.
Eur J Med Chem 130: 86-106 (2017)
China Pharmaceutical University
Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia.
Eur J Med Chem 130: 60-72 (2017)
Instituto De Qu£Mica M£Dica
Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment.
Eur J Med Chem 130: 139-153 (2017)
Sun Yat-Sen University
Vicinal diaryl azole-based urea derivatives as potential cholesterol lowering agents acting through inhibition of SOAT enzymes.
Eur J Med Chem 130: 107-123 (2017)
The Maharaja Sayajirao University Of Baroda
Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs).
Bioorg Med Chem Lett 27: 1608-1610 (2017)
Torrey Pines Institute For Molecular Studies
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
J Med Chem 60: 4780-4804 (2017)
Dipartimento Di Chimica E Tecnologie Del Farmaco "Sapienza" Universit£
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity.
J Med Chem 60: 2344-2360 (2017)
University Of Bayreuth
Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.
J Nat Prod 80: 699-706 (2017)
University Of Athens
Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors.
Cell Chem Biol 24: 281-292 (2017)
University Of Colorado
Synthesis and in vitro biological evaluation of novel quinazoline derivatives.
Bioorg Med Chem Lett 27: 1584-1587 (2017)
Key Laboratory Of The Ministry Of Education For Medicinal Resources And Natural Pharmaceutical Chemistry
Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A
Bioorg Med Chem 25: 1963-1975 (2017)
Advinus Therapeutics
Comparison of the anion inhibition profiles of theß- and¿-carbonic anhydrases from the pathogenic bacterium Burkholderia pseudomallei.
Bioorg Med Chem 25: 2010-2015 (2017)
Istituto Di Bioscienze E Biorisorse, Cnr
Design, synthesis and biological evaluation of aminobenzyloxyarylamide derivatives as selective? opioid receptor antagonists.
Eur J Med Chem 130: 15-25 (2017)
China Pharmaceutical University
Continued optimization of the M
Bioorg Med Chem Lett 27: 1356-1359 (2017)
Vanderbilt University School Of Medicine
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases andß-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Bioorg Med Chem 25: 1997-2009 (2017)
Sichuan University
Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABA
Bioorg Med Chem 25: 1901-1906 (2017)
Universit£
Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds.
Bioorg Med Chem 25: 1914-1925 (2017)
Saint Petersburg State University
Kinase-independent phosphoramidate S1P
Bioorg Med Chem Lett 27: 1371-1378 (2017)
Cardiff University
Novel conjugates of endoperoxide and 4-anilinoquinazoline as potential anticancer agents.
Bioorg Med Chem Lett 27: 1341-1345 (2017)
Soochow University
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.
Bioorg Med Chem 25: 2901-2916 (2017)
Baylor University
Synthesis, molecular docking and biological evaluation of some newer 2-substituted-4-(benzo[d][1,3]dioxol-5-yl)-6-phenylpyridazin-3(2H)-ones as potential anti-inflammatory and analgesic agents.
Bioorg Chem 71: 201-210 (2017)
Panjab University
Synthesis and biological evaluations of chalcones, flavones and chromenes as farnesoid x receptor (FXR) antagonists.
Eur J Med Chem 129: 303-309 (2017)
Chinese Academy Of Medical Sciences And Peking Union Medical College
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.
Eur J Med Chem 129: 287-302 (2017)
University Of Torino
Design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine derivatives as mTOR inhibitors.
Eur J Med Chem 129: 135-150 (2017)
Peking University
Development of New Benzenesulfonamides As Potent and Selective Na
J Med Chem 60: 2513-2525 (2017)
Bristol-Myers Squibb
Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.
J Med Chem 60: 2573-2590 (2017)
Seoul National University
Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Bioorg Med Chem 25: 1926-1938 (2017)
South Dakota State University
Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors.
Bioorg Med Chem 25: 1939-1948 (2017)
Shandong University
Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening.
Eur J Med Chem 129: 275-286 (2017)
West China Hospital Of Sichuan University
Novel 2,3-disubstituted quinazoline-4(3H)-one molecules derived from amino acid linked sulphonamide as a potent malarial antifolates for DHFR inhibition.
Eur J Med Chem 129: 251-265 (2017)
Affiliated To Sardar Patel University
Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.
J Med Chem 60: 2562-2572 (2017)
Pfizer
Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors.
J Med Chem 60: 2227-2244 (2017)
East China University Of Science And Technology
Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer's Disease.
J Med Chem 60: 2383-2400 (2017)
Forum Pharmaceuticals
Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
J Med Chem 60: 2685-2696 (2017)
University Of California
High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators.
J Med Chem 60: 2401-2410 (2017)
University Of California
Leupeptazin, a highly modified tripeptide isolated from cultures of a Streptomyces sp. inhibits cathepsin K.
Bioorg Med Chem Lett 27: 1397-1400 (2017)
University Of British Columbia
Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.
Biochemistry 56: 1865-1878 (2017)
Stony Brook University
A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction.
J Med Chem 60: 2245-2256 (2017)
Dublin Institute Of Technology
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor.
J Med Chem 60: 2361-2372 (2017)
Tu Dortmund University
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.
Eur J Med Chem 129: 159-174 (2017)
De Montfort University
Systematic variation of the benzenesulfonamide part of the GluN2A selective NMDA receptor antagonist TCN-201.
Eur J Med Chem 129: 124-134 (2017)
University Of M£Nster
Studies of the Binding of Modest Modulators of the Human Enzyme, Sirtuin 6, by STD NMR.
Chembiochem 18: 931-940 (2017)
University At Albany
Electrostatic Interactions as Mediators in the Allosteric Activation of Protein Kinase A RIa.
Biochemistry 56: 1536-1545 (2017)
University Of California San Diego
Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids.
Eur J Med Chem 129: 110-123 (2017)
Universit£
Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.
J Med Chem 60: 2439-2455 (2017)
Indiana University School Of Medicine
Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.
J Med Chem 60: 2373-2382 (2017)
University Of Iowa
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
J Med Chem 60: 1817-1828 (2017)
East China University Of Science And Technology
Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective¿-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo.
J Med Chem 60: 2526-2551 (2017)
Dr. August Wolff Gmbh & Co. Kg Arzneimittel
Design, synthesis and biological evaluation of nonsecosteroidal vitamin D
Bioorg Med Chem Lett 27: 1428-1436 (2017)
China Pharmaceutical University
Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment.
Bioorg Med Chem Lett 27: 1458-1462 (2017)
Wuxi Apptec (Shanghai)
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists.
Bioorg Med Chem Lett 27: 1364-1370 (2017)
Merck
Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of ?-amyloid-42 aggregation for the treatment of Alzheimer's disease.
Bioorg Med Chem Lett 27: 1405-1411 (2017)
Ac Immune
Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification.
Bioorg Med Chem 25: 1889-1900 (2017)
Universidade Federal De Minas Gerais
Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.
Bioorg Chem 71: 181-191 (2017)
Jamia Hamdard (Hamdard University)
Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile.
Eur J Med Chem 129: 27-40 (2017)
China Pharmaceutical University
Asymmetric total synthesis of tetrahydroprotoberberine derivatives and evaluation of their binding affinities at dopamine receptors.
Bioorg Med Chem Lett 27: 1437-1440 (2017)
Harvard Medical School
Design, synthesis and biological evaluation of thienopyrimidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors.
Eur J Med Chem 128: 293-299 (2017)
Chinese Academy Of Sciences
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT
J Med Chem 60: 1843-1859 (2017)
Suven Life Sciences
Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.
J Med Chem 60: 2470-2484 (2017)
Gedeon Richter
Identification of highly potent and selective PI3K? inhibitors.
Bioorg Med Chem Lett 27: 2849-2853 (2017)
Bristol-Myers Squibb
Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential.
Bioorg Med Chem 25: 1737-1746 (2017)
China Pharmaceutical University
Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.
J Med Chem 60: 2119-2134 (2017)
Mcgill University
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.
J Med Chem 60: 2052-2070 (2017)
Qimr Berghofer Medical Research Institute
An epigenetic modifier induces production of (10'S)-verruculide B, an inhibitor of protein tyrosine phosphatases by Phoma sp. nov. LG0217, a fungal endophyte of Parkinsonia microphylla.
Bioorg Med Chem 25: 1860-1866 (2017)
University Of Arizona
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase.
J Med Chem 60: 2271-2286 (2017)
Vernalis (R&D)
Design and Synthesis of Novel, Selective GPR40 AgoPAMs.
ACS Med Chem Lett 8: 221-226 (2017)
Merck Research Laboratories
Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2.
ACS Med Chem Lett 8: 215-220 (2017)
University Of Michigan
From Dynamic Combinatorial Chemistry to
ACS Med Chem Lett 8: 206-210 (2017)
Universit£
Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors.
ACS Med Chem Lett 8: 185-190 (2017)
Global Blood Therapeutics
Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors.
Bioorg Med Chem 25: 1852-1859 (2017)
South China Agricultural University
Potent and Selective EphA4 Agonists for the Treatment of ALS.
Cell Chem Biol 24: 293-305 (2017)
Sanford Burnham Prebys Medical Discovery Institute
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity.
Bioorg Chem 71: 160-169 (2017)
Hanoi University Of Pharmacy
Drug Discovery Targeting Bromodomain-Containing Protein 4.
J Med Chem 60: 4533-4558 (2017)
University Of Texas Medical Branch
Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors.
ACS Chem Biol 12: 1028-1037 (2017)
Promega Biosciences
Rational design of reversible inhibitors for trehalose 6-phosphate phosphatases.
Eur J Med Chem 128: 274-286 (2017)
University Of New Mexico
Discovery of an Inhibitor of the Proteasome Subunit Rpn11.
J Med Chem 60: 1343-1361 (2017)
University Of California San Diego
Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists.
Bioorg Med Chem 25: 1787-1794 (2017)
Hiroshima International University
Discovery and dimeric approach of novel Natriuretic Peptide Receptor A (NPR-A) agonists.
Bioorg Med Chem 25: 1762-1769 (2017)
Asubio Pharma
Novel 6-methoxycarbonyl indolinones bearing a pyrrole Mannich base moiety as angiokinase inhibitors.
Bioorg Med Chem 25: 1778-1786 (2017)
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1.
Bioorg Med Chem Lett 27: 1478-1483 (2017)
Eli Lilly
Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.
Eur J Med Chem 128: 247-257 (2017)
Universidade De Lisboa
New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates.
Eur J Med Chem 128: 237-246 (2017)
University Of Mazandaran
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes.
Bioorg Med Chem Lett 27: 1179-1185 (2017)
Kyung Hee University
Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.
Bioorg Med Chem Lett 27: 1159-1161 (2017)
Tohoku Medical And Pharmaceutical University
Identification of novel inverse agonists of estrogen-related receptors ERR¿ and ERRß.
Bioorg Med Chem 25: 1585-1599 (2017)
The Beckman Research Institute
Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
Bioorg Med Chem Lett 27: 1136-1140 (2017)
Sunchon National University
Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
Bioorg Med Chem 25: 1571-1584 (2017)
University Of Washington
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D
J Med Chem 60: 1478-1494 (2017)
National Institute On Drug Abuse
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship.
J Med Chem 60: 1693-1715 (2017)
European Institute Of Oncology
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration.
J Med Chem 60: 1673-1692 (2017)
European Institute Of Oncology
"Addition" and"Subtraction": Selectivity Design for Type II Maternal Embryonic Leucine Zipper Kinase Inhibitors.
J Med Chem 60: 2155-2161 (2017)
Novartis Institutes For Biomedical Research
Small Molecules Engage Hot Spots through Cooperative Binding To Inhibit a Tight Protein-Protein Interaction.
Biochemistry 56: 1768-1784 (2017)
Indiana University School Of Medicine
Discovery of phenyl acetamides as potent and selective GPR119 agonists.
Bioorg Med Chem Lett 27: 1124-1128 (2017)
Merck
The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.
J Nat Prod 80: 740-755 (2017)
Colorado Mesa University
Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
Eur J Med Chem 128: 180-191 (2017)
China Pharmaceutical University
Targeting Bacillosamine Biosynthesis in Bacterial Pathogens: Development of Inhibitors to a Bacterial Amino-Sugar Acetyltransferase from Campylobacter jejuni.
J Med Chem 60: 2099-2118 (2017)
Massachusetts Institute Of Technology
Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase.
J Med Chem 60: 2287-2304 (2017)
Universit£
Slowly on, Slowly off: Bisubstrate-Analogue Conjugates of 5-Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin.
Chembiochem 18: 790-798 (2017)
University Of Tartu
Characterisation of Photoaffinity-Based Chemical Probes by Fluorescence Imaging and Native-State Mass Spectrometry.
Chembiochem 18: 739-754 (2017)
Griffith University
The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization.
J Med Chem 60: 3552-3579 (2017)
Alkermes
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
J Med Chem 60: 1734-1745 (2017)
National University Of Singapore
Parallel fluorescent probe synthesis based on the large-scale preparation of BODIPY FL propionic acid.
Bioorg Med Chem Lett 27: 1145-1148 (2017)
Takeda Pharmaceutical
Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor.
Bioorg Med Chem Lett 27: 1243-1246 (2017)
Huazhong University Of Science And Technology
Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF
Bioorg Med Chem 25: 1556-1570 (2017)
Takeda Pharmaceutical
Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5a-reductase 2 and with cytotoxic activity in cancer cells.
Bioorg Med Chem 25: 1600-1607 (2017)
Universidad Nacional Aut£Noma De M£Xico
Design and synthesis of novel phenyl -1, 4-beta-carboline-hybrid molecules as potential anticancer agents.
Eur J Med Chem 128: 123-139 (2017)
Karnatak University
Fluorinated Chaperone-ß-Cyclodextrin Formulations forß-Glucocerebrosidase Activity Enhancement in Neuronopathic Gaucher Disease.
J Med Chem 60: 1829-1842 (2017)
University Of Sevilla
Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.
Biochemistry 56: 1559-1572 (2017)
University Of Cambridge
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators.
Bioorg Med Chem Lett 27: 1193-1198 (2017)
Goethe-University Frankfurt
Piceatannol, a natural trans-stilbene compound, inhibits human glyoxalase I.
Bioorg Med Chem Lett 27: 1169-1174 (2017)
Tokyo University Of Science
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes asa7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR.
Bioorg Med Chem Lett 27: 1261-1266 (2017)
Bristol-Myers Squibb Pharmaceutical Research Institute
Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors.
Bioorg Med Chem Lett 27: 1311-1315 (2017)
Takeda California
Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist.
Bioorg Med Chem Lett 27: 1186-1192 (2017)
Askat
Lactosamine-Based Derivatives as Tools to Delineate the Biological Functions of Galectins: Application to Skin Tissue Repair.
Chembiochem 18: 782-789 (2017)
Universit?? De Nantes
Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders.
J Med Chem 60: 2037-2051 (2017)
Dart Neuroscience
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity.
J Med Chem 60: 1768-1792 (2017)
Universit£
Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family.
J Med Chem 60: 2026-2036 (2017)
Chinese Academy Of Sciences
Transition State-Based Sialyltransferase Inhibitors: Mimicking Oxocarbenium Ion by Simple Amide.
J Med Chem 60: 2135-2141 (2017)
Peking University
Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.
J Med Chem 60: 2006-2017 (2017)
The Netherlands Institute
The Bibenzyl Canniprene Inhibits the Production of Pro-Inflammatory Eicosanoids and Selectively Accumulates in Some Cannabis sativa Strains.
J Nat Prod 80: 731-734 (2017)
Universit£
Perfluoro-tert-butyl Homoserine Is a Helix-Promoting, Highly Fluorinated, NMR-Sensitive Aliphatic Amino Acid: Detection of the Estrogen Receptor·Coactivator Protein-Protein Interaction by (19)F NMR.
Biochemistry 56: 1062-1074 (2017)
University Of Delaware
Small-Molecule Inhibitors of the SOX18 Transcription Factor.
Cell Chem Biol 24: 346-359 (2017)
The University Of Queensland
Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitor.
Bioorg Med Chem 25: 1672-1680 (2017)
University Of Toronto
Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors.
Bioorg Med Chem 25: 1666-1671 (2017)
King Saud University
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Bioorg Med Chem 25: 2531-2544 (2017)
Russian Academy Of Sciences
In search of new a-glucosidase inhibitors: Imidazolylpyrazole derivatives.
Bioorg Chem 71: 102-109 (2017)
University Of The Punjab
Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Bioorg Chem 70: 256-266 (2017)
Jaipur National University
Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As ß-glucuronidase inhibitors.
Bioorg Chem 71: 86-96 (2017)
Universiti Teknologi Mara (Uitm)
The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity.
Bioorg Med Chem Lett 27: 1233-1236 (2017)
Osaka Prefecture University
Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains.
Eur J Med Chem 128: 107-122 (2017)
Alma Mater Studiorum-University Of Bologna
Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors.
J Med Chem 60: 1946-1958 (2017)
Novartis Institutes For Biomedical Research
Active Site Binding Is Not Sufficient for Reductive Deiodination by Iodotyrosine Deiodinase.
Biochemistry 56: 1130-1139 (2017)
Johns Hopkins University
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation.
J Med Chem 60: 1892-1915 (2017)
University Of South Australia
Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase.
Eur J Med Chem 128: 88-97 (2017)
Peking University
Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
Eur J Med Chem 128: 79-87 (2017)
Gdansk University Of Technology
Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction.
Eur J Med Chem 128: 56-69 (2017)
Korea Institute Of Science And Technology (Kist)
Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
Eur J Med Chem 128: 25-35 (2017)
Federal University Of Santa Catarina
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases.
J Med Chem 60: 1247-1261 (2017)
Queen Mary University Of London
Full Sequence Amino Acid Scanning of¿-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.
J Med Chem 60: 1916-1927 (2017)
State University Of New York
Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist.
Bioorg Med Chem Lett 27: 1278-1283 (2017)
Glaxosmithkline
Identification of High-Potency Human TLR8 and Dual TLR7/TLR8 Agonists in Pyrimidine-2,4-diamines.
J Med Chem 60: 2084-2098 (2017)
University Of Minnesota
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1.
J Med Chem 60: 2148-2154 (2017)
Karolinska Institutet
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
Bioorg Med Chem Lett 27: 1247-1251 (2017)
Tohoku University
Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies.
Bioorg Chem 71: 97-101 (2017)
Csir-Indian Institute Of Chemical Biology
Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor.
J Med Chem 60: 1793-1816 (2017)
High Magnetic Field Laboratory
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
J Nat Prod 80: 334-346 (2017)
Peking University
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans.
J Med Chem 60: 1971-1993 (2017)
Pfizer
Facile dimethyl amino group triggered cyclic sulfonamides synthesis and evaluation as alkaline phosphatase inhibitors.
Bioorg Chem 71: 10-18 (2017)
University Of Karachi
ALK5 kinase inhibitory activity and synthesis of 2,3,4-substituted 5,5-dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles.
Eur J Med Chem 127: 632-642 (2017)
Palack£
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.
Nat Chem Biol 13: 389-395 (2017)
Abbvie
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.
Nat Chem Biol 13: 381-388 (2017)
Novartis Institutes For Biomedical Research
Emergence of Small-Molecule Non-RGD-Mimetic Inhibitors for RGD Integrins.
J Med Chem 60: 3241-3251 (2017)
University Of Strathclyde
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria.
J Med Chem 60: 3221-3240 (2017)
Case Western Reserve University
Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase.
J Med Chem 60: 1876-1891 (2017)
Icahn School Of Medicine At Mount Sinai
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.
J Med Chem 60: 1928-1945 (2017)
Imperial College
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.
ACS Chem Biol 12: 825-832 (2017)
Exonate
Phloroglucinol Derivatives with Protein Tyrosine Phosphatase 1B Inhibitory Activities from Eugenia jambolana Seeds.
J Nat Prod 80: 544-550 (2017)
Northeastern University
Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.
Biochemistry 56: 919-931 (2017)
Syracuse University
Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors.
Bioorg Med Chem Lett 27: 744-749 (2017)
Georgia Institute Of Technology
Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-a/ß.
Bioorg Med Chem Lett 27: 781-786 (2017)
Novartis Institutes For Biomedical Research
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokinetics.
Bioorg Med Chem Lett 27: 1062-1069 (2017)
Merck Research Laboratories
Discovery of pyrazolopyrimidine derivatives as novel inhibitors of ataxia telangiectasia and rad3 related protein (ATR).
Bioorg Med Chem Lett 27: 750-754 (2017)
Integral Biosciences
Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl)methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitors.
Bioorg Med Chem Lett 27: 729-732 (2017)
China Medical University
DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-ß aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy.
Bioorg Med Chem Lett 27: 718-722 (2017)
Sichuan University
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.
Eur J Med Chem 127: 621-631 (2017)
Universities Of Lille
Identification of allosteric binding sites for PI3Ka oncogenic mutant specific inhibitor design.
Bioorg Med Chem 25: 1481-1486 (2017)
Johns Hopkins University School Of Medicine
Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening.
Bioorg Med Chem Lett 27: 929-935 (2017)
Harvard Medical School
Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.
J Med Chem 60: 1292-1308 (2017)
Sun Yat-Sen University
Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase-4 (DPP-4), Antagonists of the C-C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol-3 Kinase? (PI3K?) Inhibitors.
J Med Chem 60: 1534-1554 (2017)
University Park Nottingham
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
J Nat Prod 80: 278-289 (2017)
University Of Barcelona
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases.
J Med Chem 60: 4101-4125 (2017)
Universit£
Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.
Bioorg Med Chem Lett 27: 759-763 (2017)
Universitat De Barcelona
Activation of anti-oxidant Nrf2 signaling by substituted trans stilbenes.
Bioorg Med Chem 25: 1423-1430 (2017)
University Of New Mexico
Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory.
Bioorg Med Chem 25: 1471-1480 (2017)
Indian Institute Of Technology (Banaras Hindu University)
Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Bioorg Chem 71: 1-9 (2017)
Panjab University
Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
Bioorg Chem 70: 237-244 (2017)
University Of Sargodha
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
J Med Chem 60: 1648-1661 (2017)
Gilead Sciences
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets.
J Med Chem 60: 527-553 (2017)
Taipei Medical University
Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
J Med Chem 60: 554-567 (2017)
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway.
J Med Chem 60: 1469-1477 (2017)
Sapienza University Of Rome
Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenase.
Bioorg Med Chem 25: 1465-1470 (2017)
Nagasaki University
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
J Med Chem 60: 3533-3551 (2017)
Shandong University
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.
J Med Chem 60: 1325-1342 (2017)
University Of Illinois College Of Pharmacy
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
J Med Chem 60: 1598-1604 (2017)
University Of Perugia
Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L.
Bioorg Med Chem Lett 27: 1304-1310 (2017)
Baylor University
Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies.
Bioorg Med Chem Lett 27: 850-854 (2017)
Guru Nanak Dev University
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR¿ and SUR agonists.
Bioorg Med Chem 25: 1496-1513 (2017)
Al-Azhar University
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.
Nat Chem Biol 13: 317-324 (2017)
Abbvie
Selective Inhibitors of Human Liver Carboxylesterase Based on aß-Lapachone Scaffold: Novel Reagents for Reaction Profiling.
J Med Chem 60: 1568-1579 (2017)
St. Jude Children'S Research Hospital
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.
J Med Chem 60: 1309-1324 (2017)
University Of Tennessee Health Science Center
Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode.
J Med Chem 60: 1417-1431 (2017)
Bristol-Myers Squibb
Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
Bioorg Med Chem 25: 1456-1464 (2017)
Abant Izzet Baysal University
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics.
Bioorg Med Chem Lett 27: 1109-1114 (2017)
Merck
Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
Bioorg Med Chem Lett 27: 1105-1108 (2017)
East China Normal University
Talaromyces marneffei Mp1p Is a Virulence Factor that Binds and Sequesters a Key Proinflammatory Lipid to Dampen Host Innate Immune Response.
Cell Chem Biol 24: 182-194 (2017)
The University Of Hong Kong
An Unusual Protector-Protégé Strategy for the Biosynthesis of Purine Nucleoside Antibiotics.
Cell Chem Biol 24: 171-181 (2017)
Wuhan University
Synthesis, characterization and biological evaluation of novel chalcone sulfonamide hybrids as potent intestinal alkaline phosphatase inhibitors.
Bioorg Chem 70: 229-236 (2017)
Comsats Institute Of Information Technology
Benzenesulphonamide inhibitors of the cytolytic protein perforin.
Bioorg Med Chem Lett 27: 1050-1054 (2017)
University Of Auckland
Positional isomers of bispyridine benzene derivatives induce efficacy changes on mGlu
Eur J Med Chem 127: 567-576 (2017)
Institute For Advanced Chemistry Of Catalonia (Iqac-Csic)
Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors.
Eur J Med Chem 127: 531-553 (2017)
Washington University
Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eur J Med Chem 127: 521-530 (2017)
Kafrelsheikh University
Discovery of a series of N-(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamides as PI3K/mTOR dual inhibitors.
Eur J Med Chem 127: 509-520 (2017)
Hangzhou Xixi Hospital
Identification of a selective inhibitor of transforming growth factorß-activated kinase 1 by biosensor-based screening of focused libraries.
Bioorg Med Chem Lett 27: 1031-1036 (2017)
Chugai Pharmaceutical
Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.
Bioorg Med Chem Lett 27: 887-892 (2017)
Beijing Institute Of Technology
Microbial hydroxylation and glycosylation of pentacyclic triterpenes as inhibitors on tissue factor procoagulant activity.
Bioorg Med Chem Lett 27: 1026-1030 (2017)
China Pharmaceutical University
A tetramic acid derivative with protein tyrosine phosphatase 1B inhibitory activity and a new nortriterpene glycoside from the Indonesian marine sponge Petrosia sp.
Bioorg Med Chem Lett 27: 999-1002 (2017)
Tohoku Medical And Pharmaceutical University
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kd inhibitors.
Bioorg Med Chem Lett 27: 855-861 (2017)
Bristol-Myers Squibb
Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.
Bioorg Med Chem Lett 27: 845-849 (2017)
China Pharmaceutical University
Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Eur J Med Chem 127: 470-492 (2017)
Ntz Lab
Binding and Proton Blockage by Amantadine Variants of the Influenza M2
J Med Chem 60: 1716-1733 (2017)
National And Kapodistrian University Of Athens
Discovery of a Phosphoinositide 3-Kinase (PI3K) ?/? Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3K? Potency in a PI3K?-Selective Template by Targeting Nonconserved Asp856.
J Med Chem 60: 1555-1567 (2017)
Gilead Sciences
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] asa7 Nicotinic Receptor Agonists.
ACS Med Chem Lett 8: 133-137 (2017)
Bristol-Myers Squibb Research And Development
Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension.
ACS Med Chem Lett 8: 128-132 (2017)
Merck Research Laboratories
Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules.
ACS Med Chem Lett 8: 124-127 (2017)
Yale University
Discovery of a Potent, Selective, and Orally Available PI3Kd Inhibitor for the Treatment of Inflammatory Diseases.
ACS Med Chem Lett 8: 118-123 (2017)
RhôNe-Poulenc Rorer
Structural Basis for the Effective Myostatin Inhibition of the Mouse Myostatin Prodomain-Derived Minimum Peptide.
ACS Med Chem Lett 8: 113-117 (2017)
Tokyo University Of Pharmacy And Life Sciences
Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists.
ACS Med Chem Lett 8: 107-112 (2017)
Ono Pharmaceutical
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.
ACS Med Chem Lett 8: 102-106 (2017)
Xavier University Of Louisiana
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with
ACS Med Chem Lett 8: 96-101 (2017)
Merck
GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved
ACS Med Chem Lett 8: 84-89 (2017)
Genentech
Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds.
ACS Med Chem Lett 8: 73-77 (2017)
Mossakowski Medical Research Centre Polish Academy Of Sciences
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.
ACS Med Chem Lett 8: 67-72 (2017)
Bristol-Myers Squibb
Covalent Guanosine Mimetic Inhibitors of G12C KRAS.
ACS Med Chem Lett 8: 61-66 (2017)
Dana Farber Cancer Institute
2-Hydroxypyridine-
ACS Med Chem Lett 8: 55-60 (2017)
Univ. Grenoble-Alpes/Cnrs
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists.
ACS Med Chem Lett 8: 49-54 (2017)
Merck
Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA
ACS Med Chem Lett 8: 43-48 (2017)
University Of Strathclyde
Novel Potentiators for Vancomycin in the Treatment of Biofilm-Related MRSA Infections via a Mix and Match Approach.
ACS Med Chem Lett 8: 38-42 (2017)
Ghent University
Electrophilic Helical Peptides That Bond Covalently, Irreversibly, and Selectively in a Protein-Protein Interaction Site.
ACS Med Chem Lett 8: 22-26 (2017)
The University Of Queensland
Great Therapeutic Potential of Peptidylarginine Deiminase 4 (PAD4) Inhibitors: Treatment of Rheumatoid Arthritis, Epigenetic Tools, Regulation of Pluripotency in Stem Cells, and More.
ACS Med Chem Lett 8: 19-21 (2017)
Therachem Research Medilab (India)
Potential Treatment of Cognitive Impairment in Schizophrenia by Phosphodiesterase 2 (PDE2) Inhibitors.
ACS Med Chem Lett 8: 17-18 (2017)
Therachem Research Medilab (India)
Targeting the Inhibition of Tryptophan 2,3-Dioxygenase (TDO-2) for Cancer Treatment.
ACS Med Chem Lett 8: 11-13 (2017)
Therachem Research Medilab (India)
Potential of Renal Outer Medullary Potassium (ROMK) Channel as Treatments for Hypertension and Heart Failure.
ACS Med Chem Lett 8: 9-10 (2017)
Therachem Research Medilab (India)
Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion.
J Med Chem 60: 941-956 (2017)
G3-Biotec
Identification of the First Selective Activin Receptor-Like Kinase 1 Inhibitor, a Reversible Version of L-783277.
J Med Chem 60: 1495-1508 (2017)
Korea University
Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione Core.
J Med Chem 60: 1611-1616 (2017)
Vanderbilt University
Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases.
J Med Chem 60: 1210-1218 (2017)
University Of California
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
J Med Chem 60: 568-579 (2017)
Universidade De Lisboa
Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain.
ACS Chem Biol 12: 724-734 (2017)
University Of Michigan
Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Bioorg Med Chem 25: 1448-1455 (2017)
Vit University
Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors.
Bioorg Med Chem Lett 27: 862-866 (2017)
Oribase Pharma
Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
Eur J Med Chem 127: 442-458 (2017)
Peking University
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
J Med Chem 60: 2215-2226 (2017)
Novartis Institutes For Biomedical Research
Disorazoles Block Group A Streptococcal Invasion into Epithelial Cells Via Interference with the Host Factor Ezrin.
Cell Chem Biol 24: 159-170 (2017)
Saarland University
Investigation of piperazine benzamides as humanß
Bioorg Med Chem Lett 27: 1094-1098 (2017)
Merck
Novel 2,4-dichlorophenoxy acetic acid substituted thiazolidin-4-ones as anti-inflammatory agents: Design, synthesis and biological screening.
Bioorg Med Chem Lett 27: 1017-1025 (2017)
Jamia Hamdard (Hamdard University)
Synthesis, anticholinesterase activity and molecular modeling study of novel carbamate-substituted thymol/carvacrol derivatives.
Bioorg Med Chem 25: 1352-1363 (2017)
Bezmialem Vakif University
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
Bioorg Med Chem 25: 813-824 (2017)
Northern Illinois University
Virtual screening and experimental validation identify novel modulators of nuclear receptor RXRa from Drugbank database.
Bioorg Med Chem Lett 27: 1055-1061 (2017)
Xiamen University
Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
Eur J Med Chem 127: 413-423 (2017)
University Of Sharjah
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking.
Eur J Med Chem 127: 398-412 (2017)
University Of Sassari
Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.
Bioorg Med Chem Lett 27: 1037-1040 (2017)
Cardiff University
Synthesis, structure-activity relationships studies of benzoxazinone derivatives as a-chymotrypsin inhibitors.
Bioorg Chem 70: 210-221 (2017)
University Of Karachi
Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.
J Med Chem 60: 1142-1150 (2017)
National Institute Of Biological Science
Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB
J Med Chem 60: 1126-1141 (2017)
National Institute On Alcohol Abuse And Alcoholism
a-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH).
J Med Chem 60: 1591-1597 (2017)
Universit£
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker.
J Med Chem 60: 1060-1075 (2017)
Bristol-Myers Squibb
Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase.
Bioorg Med Chem 25: 1076-1084 (2017)
Peking University
Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Bioorg Med Chem 25: 1143-1152 (2017)
Charles University In Prague
Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
Bioorg Med Chem 25: 1042-1056 (2017)
Sunshine Lake Pharma
Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents.
Bioorg Med Chem Lett 27: 1045-1049 (2017)
Kyorin Pharmaceutical
Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate.
Bioorg Med Chem Lett 27: 1099-1104 (2017)
Takeda California
Mechanism of Flavoprotein l-6-Hydroxynicotine Oxidase: pH and Solvent Isotope Effects and Identification of Key Active Site Residues.
Biochemistry 56: 869-875 (2017)
University Of Texas Health Science Center
Discovery of new MurA inhibitors using induced-fit simulation and docking.
Bioorg Med Chem Lett 27: 944-949 (2017)
University Of Ljubljana
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity.
Eur J Med Chem 127: 379-397 (2017)
Universit£
Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.
Eur J Med Chem 127: 369-378 (2017)
Universit£
Polar aromatic periphery increases agonist potency of spirocyclic free fatty acid receptor (GPR40) agonists inspired by LY2881835.
Eur J Med Chem 127: 357-368 (2017)
Saint Petersburg State University
Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors.
Eur J Med Chem 127: 341-356 (2017)
Griffith University
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A.
J Med Chem 60: 1000-1017 (2017)
Selcia
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis.
J Med Chem 60: 1159-1170 (2017)
University Of Florence
Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis.
J Med Chem 60: 1219-1224 (2017)
Tsinghua University
The Essential Medicinal Chemistry of Curcumin.
J Med Chem 60: 1620-1637 (2017)
University Of Minnesota
Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.
J Med Chem 60: 913-927 (2017)
Arena Pharmaceuticals
Type I DNA Topoisomerases.
J Med Chem 60: 2169-2192 (2017)
University Of Bologna
Synthesis, in vitro ß-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles.
Bioorg Chem 70: 199-209 (2017)
University Of Karachi
Discovery of novel anti-angiogenesis agents. Part 6: Multi-targeted RTK inhibitors.
Eur J Med Chem 127: 275-285 (2017)
Xi'An Jiaotong University
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
J Med Chem 60: 668-680 (2017)
University College London
Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric).
J Nat Prod 80: 196-200 (2017)
Seoul National University
Synthesis, docking, cytotoxicity, and LTA
Bioorg Med Chem 25: 1277-1285 (2017)
Mansoura University
Activation of lysine-specific demethylase 1 inhibitor peptide by redox-controlled cleavage of a traceless linker.
Bioorg Med Chem 25: 1227-1234 (2017)
Nagoya City University
Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors.
Bioorg Med Chem 25: 1286-1293 (2017)
Kurukshetra University
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds.
Eur J Med Chem 126: 1129-1135 (2017)
University Of Modena And Reggio Emilia
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Eur J Med Chem 127: 250-262 (2017)
University Of Bologna
New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT
Bioorg Med Chem 25: 1250-1259 (2017)
Universit£
Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.
Bioorg Med Chem 25: 1242-1249 (2017)
Italy
Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, A?
Eur J Med Chem 127: 174-186 (2017)
Zhejiang Chinese Medical University
Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2.
Bioorg Med Chem Lett 27: 398-402 (2017)
Binghamton University
Dithiocarbamates effectively inhibit theß-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa.
Bioorg Med Chem 25: 1260-1265 (2017)
Universit£
Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase.
Bioorg Med Chem 25: 1202-1218 (2017)
Georgia Institute Of Technology
Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Bioorg Chem 70: 173-183 (2017)
Fayoum University
Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA-Encoded Chemical Library.
Chembiochem 18: 864-871 (2017)
X-Chem Pharmaceuticals
Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A
J Med Chem 60: 681-694 (2017)
Advinus Therapeutics
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.
J Med Chem 60: 2629-2650 (2017)
Instituto De Qu£Mica M£Dica (Iqm-Csic)
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies.
J Med Chem 60: 1018-1040 (2017)
University Of Tsukuba
A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore.
Bioorg Med Chem Lett 27: 406-412 (2017)
Sri International
Peptide Macrocycle Inhibitor of Coagulation Factor XII with Subnanomolar Affinity and High Target Selectivity.
J Med Chem 60: 1151-1158 (2017)
Ecole Polytechnique F�D�Rale De Lausanne (Epfl)
A Macrocyclic Agouti-Related Protein/[Nle
J Med Chem 60: 805-813 (2017)
University Of Minnesota
Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes.
J Med Chem 60: 710-721 (2017)
Lexicon Pharmaceuticals
Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold.
J Med Chem 60: 658-667 (2017)
The University Of Queensland
Model-Based Discovery of Synthetic Agonists for the Zn
J Med Chem 60: 886-898 (2017)
University Of Copenhagen
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms.
ACS Chem Biol 12: 564-573 (2017)
Universitätsklinikum Frankfurt
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A.
Bioorg Med Chem Lett 27: 675-678 (2017)
U.S. Army Medical Research Institute Of Infectious Diseases
Discovery of new selective glucocorticoid receptor agonist leads.
Bioorg Med Chem Lett 27: 437-442 (2017)
Bayer Pharma
Synthetic strategy for increasing solubility of potential FLT3 inhibitor thieno[2,3-d]pyrimidine derivatives through structural modifications at the C
Bioorg Med Chem Lett 27: 496-500 (2017)
Yonsei University
Neuritogenic activity of bi-functional bis-tryptoline triazole.
Bioorg Med Chem 25: 1195-1201 (2017)
Chiang Mai University
Discovery of imidazopyridine derivatives as novel c-Met kinase inhibitors: Synthesis, SAR study, and biological activity.
Bioorg Chem 70: 126-132 (2017)
China Pharmaceutical University
Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives.
Bioorg Chem 70: 118-125 (2017)
Cumhuriyet University
Synthesis, molecular docking studies of hybrid benzimidazole as a-glucosidase inhibitor.
Bioorg Chem 70: 184-191 (2017)
Universiti Teknologi Mara (Uitm)
Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
Cell Chem Biol 24: 55-65 (2017)
Peking University
X-ray structure based evaluation of analogs of citalopram: Compounds with increased affinity and selectivity compared with R-citalopram for the allosteric site (S2) on hSERT.
Bioorg Med Chem Lett 27: 470-478 (2017)
3D-2Drug
Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Bioorg Med Chem Lett 27: 413-419 (2017)
Karos Pharmaceuticals
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
Bioorg Med Chem 25: 1172-1182 (2017)
Csir Biosciences
Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
Bioorg Med Chem Lett 27: 484-489 (2017)
Instituto Universitario De Bio-Org£Nica (Cibican)
Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines.
Eur J Med Chem 126: 1118-1128 (2017)
Masaryk University
Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities.
Eur J Med Chem 126: 1083-1106 (2017)
East China Normal University
Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB).
Bioorg Med Chem 25: 897-911 (2017)
Uppsala University
Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors.
Bioorg Med Chem 25: 1320-1328 (2017)
Dana-Farber Cancer Institute
Design, synthesis and biological evaluation of indolin-2-one-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase3 (FLT3).
Eur J Med Chem 127: 72-86 (2017)
East China University Of Science And Technology
Ring-opened tetrahydro-¿-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.
Eur J Med Chem 127: 115-127 (2017)
Taipei Medical University
Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC.
Eur J Med Chem 127: 10-21 (2017)
Beni-Suef University
Structural Insights into the Inhibition of Tubulin by the Antitumor Agent 4ß-(1,2,4-triazol-3-ylthio)-4-deoxypodophyllotoxin.
ACS Chem Biol 12: 746-752 (2017)
Huazhong Agricultural University
A structure-guided optimization of pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of EGFR
Eur J Med Chem 126: 1107-1117 (2017)
Guangzhou Institutes Of Biomedicine And Health
Ligand Discovery for a Peptide-Binding GPCR by Structure-Based Screening of Fragment- and Lead-Like Chemical Libraries.
ACS Chem Biol 12: 735-745 (2017)
Stockholm University
Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry.
J Med Chem 60: 263-272 (2017)
University Of Chinese Academy Of Sciences
Design, synthesis, and biological activity of 4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl-phenylbenzamide derivatives as BCR-ABL kinase inhibitors.
Bioorg Med Chem Lett 26: 5830-5835 (2016)
Beijing University Of Technology
Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT
Bioorg Med Chem 25: 38-52 (2017)
Universit£
Discovery of novel polycyclic spiro-fused carbocyclicoxindole-based anticancer agents.
Eur J Med Chem 126: 1071-1082 (2017)
Sichuan University And Collaborative Innovation Center For Biotherapy
Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitors.
Eur J Med Chem 126: 1056-1070 (2017)
Hangzhou Xixi Hospital
Monascustin, an Unusual¿-Lactam from Red Yeast Rice.
J Nat Prod 80: 201-204 (2017)
Beijing Union University
Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5'-Methylthioadenosine Phosphorylase.
ACS Chem Biol 12: 464-473 (2017)
Albert Einstein College Of Medicine
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
ACS Chem Biol 12: 444-455 (2017)
University Of California Riverside
Sulfonamide inhibition profile of the¿-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis.
Bioorg Med Chem Lett 27: 490-495 (2017)
Istituto Di Bioscienze E Biorisorse
5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations.
Bioorg Med Chem 25: 857-863 (2017)
Riga Technical University
A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.
Cell Chem Biol 24: 98-109 (2017)
Mcmaster University
Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kd inhibitors.
Bioorg Med Chem Lett 27: 679-687 (2017)
Astrazeneca
An efficient anticoagulant candidate: Characterization, synthesis and in vivo study of a fondaparinux analogue Rrt1.17.
Eur J Med Chem 126: 1039-1055 (2017)
Nankai University
Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
Eur J Med Chem 126: 983-996 (2017)
University Of Auckland
Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands.
Bioorg Med Chem Lett 27: 666-669 (2017)
West Virginia University School Of Pharmacy
Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase.
Bioorg Med Chem Lett 27: 530-532 (2017)
Hunan University Of Science And Technology
Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Bioorg Med Chem 25: 1030-1041 (2017)
Sichuan University
Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.
Bioorg Med Chem 25: 1004-1013 (2017)
Columbia University
Structure-guided development of covalent TAK1 inhibitors.
Bioorg Med Chem 25: 838-846 (2017)
Harvard Medical School
Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors.
Bioorg Med Chem 25: 886-896 (2017)
Shenyang Pharmaceutical University
Ostalactones A-C,ß- ande-Lactones with Lipase Inhibitory Activity from the Cultured Basidiomycete Stereum ostrea.
J Nat Prod 79: 3148-3151 (2016)
Konkuk University
Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activity.
Eur J Med Chem 126: 954-968 (2017)
Biomedical Research Foundation Academy Of Athens (Brfaa)
Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.
J Med Chem 60: 787-796 (2017)
Universit£
Design and Synthesis of a Series of l-trans-4-Substituted Prolines as Selective Antagonists for the Ionotropic Glutamate Receptors Including Functional and X-ray Crystallographic Studies of New Subtype Selective Kainic Acid Receptor Subtype 1 (GluK1) Antagonist (2S,4R)-4-(2-Carboxyphenoxy)pyrrolidin
J Med Chem 60: 441-457 (2017)
Mcgill University
Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines.
J Med Chem 60: 1746-1767 (2017)
Newcastle University
Structure-Based Design of Tricyclic NF-?B Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K).
J Med Chem 60: 627-640 (2017)
Genentech
Fluorescent Inhibitors as Tools To Characterize Enzymes: Case Study of the Lipid Kinase Phosphatidylinositol 4-Kinase IIIß (PI4KB).
J Med Chem 60: 119-127 (2017)
Academy Of Sciences Of The Czech Republic
Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIß (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology.
J Med Chem 60: 100-118 (2017)
Academy Of Sciences Of The Czech Republic
Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen.
J Med Chem 60: 180-201 (2017)
The Institute Of Cancer Research
Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
Bioorg Med Chem Lett 27: 582-585 (2017)
Bristol-Myers Squibb Research And Development
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity.
J Med Chem 59: 10974-10993 (2016)
Centro De Investigaci£N Lilly S.A. Avda. De La Industria
In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
J Med Chem 59: 10929-10945 (2016)
Universidad De Navarra
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P
J Med Chem 59: 11138-11147 (2016)
Bristol-Myers Squibb
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors.
J Med Chem 59: 11079-11097 (2016)
Astrazeneca
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.
J Med Chem 59: 11039-11049 (2016)
Merck Research Laboratories
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells.
J Med Chem 59: 11120-11137 (2016)
University Of Manchester
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe.
J Med Chem 60: 695-709 (2017)
Glaxosmithkline
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors.
J Med Chem 60: 1105-1125 (2017)
Amgen
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
J Med Chem 60: 1262-1271 (2017)
Health & Science University
Curated by BindingDB
Curated by ChEMBL